Judicial Greffe
Patents Database
Search Results
| Jersey Registration | Proprietor | Invention | More |
| P 1 | MERCK & CO. INC. | Method for the production of vitamin substances | Details |
| P 2 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | New organic acid having plant growth promoting properties, and to active derivatives thereof, in partiuclar salts and esters. The invention further relates to compositions for agricultural use containing the new acid or an active derivative thereof. | Details |
| P 3 | ETABLISSEMENT POUR MATERIAUX DE CONSTRUCTION/F.L.SMIDTH & CO. A/S | Method of and apparatus for manufacturing endless fibro-cement sheets. | Details |
| P 4 | ETABLISSEMENT POUR MATERIAUX DE CONSTRUCTION/F.L. SMIDTH & CO. A/S | Improvements in or relatingto Pipe Joints or Couplings | Details |
| P 5 | ETABLISSEMENT POUR MATERIAUX DE CONSTRUCTION/F.A.SMIDTH & CO. S/A | Improvements in or relating to the manufacture of Fibro-cement pipes | Details |
| P 6 | J.R. GEIGY A.G. | Manufacture of aqueous emulsions for insecticidal purposes | Details |
| P 7 | J.R. GEIGY A.G. | Manufacture of insecticidal compositions and the resulting products | Details |
| P 8 | BASIL KENNETH QUENTIN | Improvements in apparatus for soil sterilisation | Details |
| P 9 | THE DOW CHEMICAL COMPANY | Compositions relating to vegetation growth control | Details |
| P 10 | SELLECK NICHOLLS & COMPANY LIMITED | Improvements in or relating to the Manufacture of Building Blocks | Details |
| P 11 | jan herbert farquharson kent | Improvements in buffing machines for tyres | Details |
| P 12 | Jan Herbert Farquharson Kent | Method of re-treading tyres | Details |
| P 13 | Power's & Deane, Ransome's Limited | Improvements in Portal Frames | Details |
| P 14 | Ernst Johan Jens Henriksen | Improvements in or relating to writing instruments | Details |
| P 15 | The Imperial Tobacco Company Ltd | Improved method of treating tobacco | Details |
| P 16 | The Imperial Tobacco Company | Improved method and apparatus for treating tobacco | Details |
| P 17 | Elliott Beresford and Son Limited | Improvements in sliding doors and windows and frames therefor | Details |
| P 18 | Montecatini Societa Generale per l'Industria Mineraria e Chimica/K Zeigler | Method for polymerizatin of Olefins and the Linear High Molecular Weight Polymers produced thereby | Details |
| P 19 | Montecatini Societa Generale per l'Industria Mineraria e Chimica/K Ziegler | Method of selectively polymerising Alpha-Olefins | Details |
| P 20 | American Cyanamid Company | Preparation for new antibiotics designated demethyltetracyclines | Details |
| P 21 | Harry Ridehalgh | Improvements relating to Blocks for Forming or Protecting Marine Structures | Details |
| P 22 | Elliott Beresford & Son Limited | Improvements in sliding doors and windows and frames therefor | Details |
| P 23 | The Imperial Tobacco Company Limited | Improved Tobacco Product and Method of its Production | Details |
| P 24 | Cordar Limited | Improvements in or relating to roof, window and like lights | Details |
| P 25 | CORDAR LIMITED | Improvements in, or relating to, windows, roof lights and the like | Details |
| P 26 | OWSIEJ BARON | Improvements in and relating to internal telephone systems | Details |
| P 27 | THOMSON BROTHERS LIMITED, THOMAS GRAHAM OFFLOW & ROBERT ARTHUR FINCH | Improvements in the manufacture of built-up pots and containers | Details |
| P 28 | FREDERICK WILLIAM SPROOLES | Improvements in or relating to open fire domestic boilers for heating & hot water supply systems | Details |
| P 29 | HOVERCRAFT DEVELOPMENT LIMITED | Improvements in or relating to vehicles for travelling over land and or water | Details |
| P 30 | TAKEDA PHARMCEUTICAL INDUSTRIES LIMITED | Derivativs of Thiamine and their production | Details |
| P 31 | Societe Industrielle du Caoutchouc Regenere | Improvements in or relating to Safety Footwear such as boots made of moulded rubber or plastics | Details |
| P 32 | ELI LILLY AND COMPANY | Aliphatic sulfate Salts of Esters of Erythromycin or Erythromycin B | Details |
| P 33 | VOLMER STORMLY HANSEN | Improvements in or relating to watering units | Details |
| P 34 | MURPHY RADIO LIMITED | Improvement in an relating to Noise Suppression in Radio Receivers | Details |
| P 35 | BRITISH AMERICAN TOBACCO COMPANY LIMITED | Improvements in or relating to Smoking Tobacco Product and Method of Making the Same | Details |
| P 36 | BRITISH AMERICAN TOBACCO COMPANY LIMITED | Improvements relating to filter cigarettes | Details |
| P 37 | BRITISH AMERICAN TOBACCO COMPANY LIMITED | Improvements relating to the testing of cigarette filters | Details |
| P 38 | FERRANTI LIMITED | Improvements relating to oil filled transformers | Details |
| P 39 | COSDEN OIL AND CHEMICAL COMPANY | Method and apparatus for continuous exothermc reactions | Details |
| P 40 | DAVID SHARP | Improvements in the construction of greenhouse walls | Details |
| P 41 | KORATRON COMPANY, INC | Press-Free Crease Retained Garments and Method of Manufacture thereof | Details |
| P 42 | PHILIP MORRIS INCORPORATED | Plastic Cigarette Container | Details |
| P 43 | C.F. BOEHRINGER & SOEHNE G.M.B.H. | New Benzene-Sulphonyl-Semicarbazides | Details |
| P 44 | JOHANNES ANTONIUS WILHELMUS PETRUS VAN BERGEN | Improvements in or relating to Ear-Ornament Clips | Details |
| P 45 | MERCK & COMPANY, INC. | Coccidiostatic compositions comprising p-Aminobenzioc Acid Derivatives | Details |
| P 46 | WILLIAM THOMAS WILLIAMS | Method of and means for moulding articles | Details |
| P 47 | LIGGETT & MYERS INCORPORATED | Filter Material | Details |
| P 48 | MONRO (GUERNSEY) LIMITED, JOHN STEWART BROOKES AND FREDERICK CHANDLER | Improvements in or relating to Trays and like Open Topped Boxes | Details |
| P 49 | THE BRITISH PETROLEUM COMPANY LIMITED | Process for recovering prue yeasts | Details |
| P 50 | THE BRITISH PETROLEUM COMPANY LIMITED | Improvements in the production of yeasts | Details |
| P 51 | ROHM & HASS COMPANY | Herbicidal Compositions | Details |
| P 52 | ROHM & HAAS COMPANY | Herbicidal Composition | Details |
| P 53 | YOSHINAGA PRINCE KABUSHIKI KAISHA | Valve Construction | Details |
| P 54 | MERCK & CO. INC. | Indole Derivatives | Details |
| P 55 | AQUA-CHEM, INC. | Method and apparatus for Distillation | Details |
| P 56 | AQUA-CHEM, INC. | a Multiple Stage Flash Evaporator | Details |
| P 57 | BARTER & SONS LIMITED | Apparatus for producing carbondioxide for the treatment of growing plants | Details |
| P 58 | HOVERCRAFT DEVELOPMENT LIMITED | Improvements in or relating to vehicles for travelling over land and/or water | Details |
| P 59 | HOVERCRAFT DEVELOPMENT LIMITED | Vehicle for travelling over land and/or water | Details |
| P 60 | HOVERCRAFT DEVELOPMENT LIMITED | Vehicle for travelling over land and/or water | Details |
| P 61 | HOVERCRAFT DEVELOPMENT LIMITED | Vehicle for travelling over land and/or water | Details |
| P 62 | TEXTRON INC. | Expansible linkage for use in making watchband or similar article of jewelery | Details |
| P 63 | THE BRITISH PETROLEUM COMPANY LIMITED | Process for the removal of straight chain hydrocarbons from petroleum | Details |
| P 64 | HOVERCRAFT DEVELOPMENT LIMITED | Improvements in or relating to vehicles for travelling over land and/or water | Details |
| P 65 | HOVERCRAFT DEVELOPMENT COMPANY | Vehicle for travelling over land and/or water | Details |
| P 66 | JACK PRODGER BOWER | Improvements in Bottle Pourers | Details |
| P 67 | HOVERCRAFT DEVELOPMENT LIMITED | Improvements in or relating to vehicles for travelling over land and/or water | Details |
| P 68 | HOVERCRAFT DEVELOPMENT LIMITED | Vehicle for travelling over water | Details |
| P 69 | CIBA-GEIGY AG | Process for the production of New Thiophosphoric Acid Esters | Details |
| P 70 | THE BRITISH PETROLEUM COMPANY LIMITED | Process for the removal of straight chian hydrocarbons from petroleum fractions | Details |
| P 71 | THE BRITISH PETROLEUM COMPANY LIMITED | Improvements in the production of Micro-Organisms from Hydrocarbons | Details |
| P 72 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Herbicides | Details |
| P 73 | THE BRITISH PETROLEUM COMPANY LIMITED | Improvements in the production of Micro-Organisms from Hydrocarbons | Details |
| P 74 | THE BRITISH PETROLEUM COMPANY LIMITED | Improvements in the production of Micro-Organisms from Hydrocarbons | Details |
| P 75 | F. HOFFMANN-LA ROCHE & CO., AKTIENGESELLSCHAFT | Benzodiazepine Derivatives | Details |
| P 76 | HOVERCRAFT DEVELOPMENT LIMITED | Vehicles for travelling over land and/or water | Details |
| P 77 | SOCIETE INDUSTRIELLE DU CAOUTCHOUC REGENERE | Process for Moulding Footwear having reinforced elements | Details |
| P 78 | FARBWERKE HOECHST AKTIENGESELLSCAHFT VORMALS MEISTER LUCIUS & BRUNING | Fungicidal preparations | Details |
| P 79 | FARBWEKE HOECHST AKTIENGESELLSCHAFT, VORMALS MEISTER LUCIUS & BRUNING | Fungicidal preparations | Details |
| P 80 | FISONS FERTILIZERS LIMITED | Liquid fertilizers | Details |
| P 81 | NATIONAL RESEARCH DEVELOPMENT CORPORATION | Crop Growing Device | Details |
| P 82 | TAKEDA PHARMACEUTICAL INDUSTRIES LTD | Method for seaoning foodstuff | Details |
| P 83 | PARKE DAVIES AND COMPANY INC. | New benzanilide compounds and methods for their production | Details |
| P 84 | POLYCELL HOLDINGS LIMITED | New and useful method and means of Lining Wall, Ceiling, Floor and Other Surfaces | Details |
| P 85 | PAN BRITANNICA INDUSTRIES LIMITED | Means for, and a method of, Cultivating Plants | Details |
| P 86 | HUGH BUTLER FOLLIOTT | Improvements in Seedling Pots of Soil, Compost or the like | Details |
| P 87 | BOEHRINGER MANNHEIM G.M.B.H. | New Nitrofuryl Derivatives | Details |
| P 88 | BOEHRINGER MANNHEIM G.M.B.H. | New Nitrofuryl Derivatives | Details |
| P 89 | GENERALE ALIMENTAIRE G.A.S.A. | Process and a machine for continuous production of pieces | Details |
| P 90 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Pharmaceutical Compositions comprising Aryloxy-Aliphatic Carboxylic Acids and/or Arylimino-Aliphatic Carboxylic Acids, their Esters and Salts | Details |
| P 91 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Naphthoxy-Substituted Alkanolamines | Details |
| P 92 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Parmaceutical Compositions, comprising Naphthalene Derivatives | Details |
| P 93 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Purification of Halothane | Details |
| P 94 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Purification of Halothane | Details |
| P 95 | F. HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT | Novel 1, 4-Benzodiazepine Derivatives | Details |
| P 96 | RANK XEROX LIMITED | Xerographic Apparatus | Details |
| P 97 | RANK XEROX LIMITED | Improvements in Xerographic Reproducing Apparatus | Details |
| P 98 | RANK XEROX LIMITED | Contact Heat Fusing Device | Details |
| P 99 | RANK XEROX LIMITED | Copy Counting | Details |
| P 100 | RANK XEROX LIMITED | Electrophotographic Element | Details |
| P 101 | FISONS HORTICULTURE LIMITED | Fertilizers | Details |
| P 102 | FISONS FERTILIZERS LIMITED | Compost | Details |
| P 103 | FISONS HORTICULTURE LIMITED | Fertilizers | Details |
| P 104 | FARBWERKE HOECHST AKTIENGESELLSCHAFT, VORMALS MEISTER LUCIUS & BRUNING | Benzenesulphonyl-Ureas and process for their manufacture | Details |
| P 105 | CIBA-GEIGY AG | New Pyrazolyl Carbamic Acid Derivatives and processes for their production | Details |
| P 106 | MERCK & CO., INC | Amino Acid Derivatives related to L-Phenylalanine | Details |
| P 107 | CAMERON IRRIGATION COMPANY LIMITED | Improvements in and relating to Nozzles for Irrigation Apparatus | Details |
| P 108 | CAMERON IRRIGATION COMPANY LIMITED | Improvements in and relating to Irrigation Apparatus | Details |
| P 109 | R.T.Z. METALS LIMITED | Improvements in or relating to Glazing Bars and Chips | Details |
| P 110 | MICHAEL JOHN WOLFINDEN | Cladding method and means | Details |
| P 111 | THE NATIONAL RESEARCH DEVELOPMENT CORPORATION | Apparatus for Detecting Gases | Details |
| P 112 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Fabrics and textile articles made from bulk filament yarn | Details |
| P 113 | SIMON-CARVES LIMITED | Improvements in or relating to Desalination | Details |
| P 114 | HOVERCRAFT DEVELOPMENT LIMITED | Improvements relating to Means for Bounding a space for Receiving Pressurised Gas | Details |
| P 115 | CONTINENTAL OIL COMPANY | Depth Controller for a Subaqueous Elongate Member such as s Seismic Detector Cable | Details |
| P 116 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Improvements in and relating to methods for making Modified False Twist Crimped Bulked Yarns | Details |
| P 117 | J.R. GEIGY A.G. | New Fungicidal Compositions | Details |
| P 118 | RHONE-POULENC | Phenthiazine Derivatives | Details |
| P 119 | AGRIPAT S.A. | New Amino Azacycloheptanones and process for their production | Details |
| P 120 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | A process for the manufacture of improved False-Twist-Crimped Bulked Filament Yarn | Details |
| P 121 | FIL-TIP CORPORATION | Improvements in or relating to Tobacco Smoking Structures | Details |
| P 122 | BUCKMAN LABORATORIES INC | Heterocyclic Thiocyanates | Details |
| P 123 | FARBWERKE HOECHST AKTIENGESELLSCHAFT | Benzenesulphonyl-Ureas and Process for their manufacture | Details |
| P 124 | HOVERCRAFT DEVELOPMENT LIMITED | Improvements relating to Gas-Cushion Vehicles | Details |
| P 125 | FARBWERKE HOECHST AKTIENGESELLSCHAFT, VORMALS MEISTER LUCUIS & BRUNING | Benzenesulphonyl-Ureas and process for their manufacture | Details |
| P 126 | FARBENFABRIKEN BAYER AKTIENGESELLSCHAFT | Esters of Thiophosphorus Acids | Details |
| P 127 | TETRA MOLECTRIC LIMITED | Improvements in and relating to Ignition Devices | Details |
| P 128 | SCHERICO LTD | 5-Substituted Aza - Dibenzo - Cycloheptenes and the preparation thereof | Details |
| P 129 | GEIGY (U.K.) LIMITED | Pharmaceutical Compositions | Details |
| P 130 | TELEFUNKEN PATENTVERWERTUNGSGESELLSCHAFT MIT BESCHRANKTER HAFTUNG | Improvements relating to Demodulating Circuits for Colour Television Receivers | Details |
| P 131 | TELEFUNKEN PATENTVERWETUNGSGESELLSCHAFT MIT BESCHRANKTER HAFTUNG | Improvements relating to Colour Television Systems and Receivers therefor | Details |
| P 132 | TELEFUNKEN PATENTVERWERTUNGSGESELLSCHAFT MIT BESCHRANKTER HAFTUNG | Improvements in or relating to Colour Television Receivers | Details |
| P 133 | RHONE-POULENC S.A. | Imidazole Derivatives | Details |
| P 134 | UNITED KINGDOM ATOMIC ENERGY AUTHORITY | Improvements in or relating to desalination | Details |
| P 135 | SCHERICO LIMITED | A Novel Antibiotic, methods for its production and therapeutic compositions containing it | Details |
| P 136 | SCHERICO LIMITED | Novel Di-Esters | Details |
| P 137 | SCHERICO LIMITED | Novel Steroids and processes for the manufacture thereof | Details |
| P 138 | FISONS LIMITED | Substituted Benzimidazole-(1)-Carboxylates | Details |
| P 139 | FISONS LIMITED | Herbicidal compositions | Details |
| P 140 | RONSON PRODUCTS LIMITED | Improvements relating to Ignition Devices | Details |
| P 141 | MERCK & CO. INC. | Hydrazino Acids | Details |
| P 142 | BERT BRIERLEY | Improvements in or relating to tiles or slabs | Details |
| P 143 | LA NATIONALE S.A. | Improvements relating to Ignition Devices | Details |
| P 144 | THE WELLCOME FOUNDATION LIMITED | Cell Strains | Details |
| P 145 | SIMON-CARVES LIMITED | Improvements in or relating to desalination | Details |
| P 146 | SIMON-CARVES LIMITED | Improvements in or relating to desalination | Details |
| P 147 | CONTINENTAL OIL COMPANY | Method of Subterranean Well Bore Completion and conduits for use therein | Details |
| P 148 | ELI LILLY AND COMPANY | 7-Alpha-Amino-3-Methyl Cephalosporin analogues, Pharmaceutical compositions comprising the same and processes for preparing the same | Details |
| P 149 | BASIL KENNETH QUENTIN | Improvements in apparatus for soil sterilisation | Details |
| P 150 | RONSON CORPORATION | Improvements relating to Ignition Devices | Details |
| P 151 | SMITH KLINE & FRENCH LABORATORIES | Anthelmintic Compositons containing Benzimidazole Derivatives | Details |
| P 152 | BEN TAYLOR | Improvements in or relating to Double Glazing | Details |
| P 153 | SCHERICO LTD. | Novel, 1,2,4-Benzothiadiazine-1, 1-Dioxides and processes for their manufacture | Details |
| P 154 | JAMES ALEXANDER SKENE DURNO | Improvements in Agricultural Implements | Details |
| P 155 | RECHERCHE ET INDUSTRIE THERAPEUTIQUES, R.I.T. | Attenuated Live Rubella Virus Vaccine and method of production | Details |
| P 156 | FISONS FERTILIZERS LIMITED | Composts | Details |
| P 157 | TELEFUNKEN PATENTVERWERTUNGSGESELLSCHAFT MIT BESCHRANKTER HAFTUNG | Improvements in or relating to Colour Television Receivers | Details |
| P 158 | ROUSSEL-UCLAF | New steroid compositions, compositions incorporationg them, and processes for their production | Details |
| P 159 | ROUSSEL-UCLAF | New steroid compositions, compositions incorporating them and processes for their preparation | Details |
| P 160 | SCHERICO LIMITED | Novel Benzazepines and processes for making same | Details |
| P 161 | SCHERICO LIMITED | Substituted Nicotinic Acids and method for the manufacture thereof | Details |
| P 162 | ROUSSEL-UCLAF | Benzodiazepine Derivatives | Details |
| P 163 | SCHERING AKTIENGESELLSCHAFT | Salts of Carbamic Acid Esters and Thiocarbamic Acid Esters having a fungicidal and fungistatic action | Details |
| P 164 | MERCK & CO. INC. | Improvements in and relating to orthopedic devices | Details |
| P 165 | MERCK & CO. INC. | Haloaryloxyacetic Acid Esters and Amides | Details |
| P 166 | MERCK & CO. INC. | Compositions comprising L-Dopa | Details |
| P 167 | E.I. DU PONT DE NEMOURS AND COMPANY | 1-Carbamoyl-N-(Substituted Carbamoyloxy) Thioformimidates and their use as pesticides | Details |
| P 168 | WILKINSON SWORD LIMITED | Improvements in and relating to shaving units and dispensors therefor | Details |
| P 169 | WILKINSON SWORD LIMITED | Improvements in and relating to shaving units and razors incorporating such shaving units | Details |
| P 170 | D & T ENGINEERS LIMITED | Tyre Kerbing Strip Machine | Details |
| P 171 | EDWARD T. DICKER | Improvements relating to building construction | Details |
| P 172 | EDWARD T. DICKER | Method of structural construction | Details |
| P 173 | RHONE-POULENC S.A. | (3-Benzoylphenyl) Alkanoic Acids | Details |
| P 174 | SMITH KLINE & FRENCH LABORATORIES | Improvements in or relating to Hypotensive 1, 4-Dehydropyridines | Details |
| P 175 | SCHERICO LTD. | Novel Benzodiazepines and process for their manufacture | Details |
| P 176 | RONSON PRODUCTS LIMITED | Improvements relating to Piezo-Electric Ignition Devices | Details |
| P 177 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Growth promotion | Details |
| P 178 | NATIONAL RESEARCH DEVELOPMENT CORPORATION | Cyclopropane Carboxylic Acid Derivatives and their use as insecticides | Details |
| P 179 | MERCK & CO. INC. | Halo-substituted 5-Phenylbenzoic Acids and their derivatives | Details |
| P 180 | RHONE-POULENC S.A. | New Phenthiazine derivatives | Details |
| P 181 | S.P.A. OFFICINE MACCAFERRI | Improvements relating to Gabions | Details |
| P 182 | AGRIPAT S.A. | 4,4'-Dibromo-Benzilic Acid and Esters and Acaricidal and Insecticidal Composition containing them | Details |
| P 183 | FUMIHIKO UMEZAWA AND KIDEFUMI UMEZAWA | Process for treating hair | Details |
| P 184 | JACK BLACKBURN | Improvements in or relating to the production of pavement-like sites | Details |
| P 185 | PAUL SCHRAUDENBACH | Paving block | Details |
| P 186 | PAUL SCHRAUDENBACH | Paving block | Details |
| P 187 | MERCK & CO., INC. | a- Hydrazino Acids | Details |
| P 188 | FARBWERKE HOECHST AKTIENGESELLSCHAFT, VORMALS MEISTER LUCIUS & BRUNING | Benzene-Sulphonamides and process for preparing them | Details |
| P 189 | ALLEN AND HANBURY'S LIMITED | Phenylaminoethanol Derivatives | Details |
| P 190 | FISONS PEST CONTROL LIMITED | Mucononitriles and their use as pesticides | Details |
| P 191 | MAY & BAKER LIMITED | Benzene Derivatives | Details |
| P 192 | WILKINSON SWORD LIMITED | Improvements in or relating to razor blade dispensers | Details |
| P 193 | WILKINSON SWORD LIMITED | Improvements in or relating to shaving devices | Details |
| P 194 | MERCK & CO. INC. | Substituted Indenylacetic Acids and their derivatives | Details |
| P 195 | INTERNATIONAL STANDARD ELECTRIC CORPORATION | Radio Navigation System | Details |
| P 196 | INTERNATIONAL STANDARD ELECTRIC CORPORATION | Doppler Radio Navigation System | Details |
| P 197 | SCHERING AKTIENGESELLSCHAFT | 1,3,4,-Thiadiazoles | Details |
| P 198 | SCHERING AKTIENGESELLSCHAFT | Herbicidal Preparations and their use | Details |
| P 199 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Plastic Containers and Method of Sealing them | Details |
| P 200 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Plastic Containers | Details |
| P 201 | FISONS PHARMACEUTICALS LIMITED | Substituted Benzodipyrones | Details |
| P 202 | MERCK & CO., INC. | Indomethacin Suppossitories | Details |
| P 203 | BAYER AKTIENGESELLSCHAFT | N-Substituted 5-Amino-1,3,4-Thiadiazoles | Details |
| P 204 | BAYER AKTIENGESELLSCHAFT | N-Tritylimidazole | Details |
| P 205 | BINISHELLS S.P.A. | Method for erecting edifices | Details |
| P 206 | CHARLES E. FROSST & CO. | Thiadiazole Derivatives | Details |
| P 207 | CHARLES E. FROSST & CO. | Preparation of Thiadiazole Derivatives | Details |
| P 208 | FISONS PHARMACEUTICAL COMPOSITION | Pharmaceutical Composition | Details |
| P 209 | FISONS PHARMACEUTICALS LIMITED | Drug for use in Pharmaceutical Composition | Details |
| P 210 | JAMES ROBERT PELMORE | Method of Strengthening Roofs | Details |
| P 211 | ELI LILLY AND COMPANY | Substituted Phenylalkanoic Acids and derivatives thereof | Details |
| P 212 | ELI LILLY AND COMPANY | 3-Mercaptothiazole or Mercaptotetrazole Cephalosporins and process for preparing the same | Details |
| P 213 | ELI LILLY AND COMPANY | Tetrazole Compounds | Details |
| P 214 | FISONS LIMITED | Compost | Details |
| P 215 | FISONS LIMITED | Composts | Details |
| P 216 | COMPUTER PATENT ANNUITIES | Improvements in Space Heaters | Details |
| P 217 | CHRISTOPHER GEORGE WILKINS | Improvements in or relating to Perspective Drawing Apparatus | Details |
| P 218 | ALLEN & HANBURYS LIMITED | Phenylaminoethanol Derivatives | Details |
| P 219 | ELI LILLY AND COMPANY | Sweetened Compositions | Details |
| P 220 | ELI LILLY AND COMPANY | 6-Triflouromethyl-Tryptophane and process for producing the same | Details |
| P 221 | SCHERICO LIMITED | Antibiotic 66-40 and methods for its production | Details |
| P 222 | FISONS LIMITED | Powder Blowing Device | Details |
| P 223 | WHITBREAD & COMPANY LIMITED | Improvements relating to beer dispensing | Details |
| P 224 | SMITH KLINE CORPORATION | a-aminoalkyl-4-hydroxy-3-ureidobenzyl alcohols | Details |
| P 225 | SMITH KLINE CORPORATION | Hydroxy-2-piperidinylcarbinols | Details |
| P 226 | STANLEY BARKER | A dispensing device for media in pressurised containers | Details |
| P 227 | CIBA-GEIGY (U.K.) LIMITED | Treatment of Water or Aqueous Systems | Details |
| P 228 | RUDY W. GUNNERMAN | Method for producing a heat barrier | Details |
| P 229 | ACTO MANUFACTURING CO., INC. | Demand Delivery Watering Valve for animals | Details |
| P 230 | BAYER AKTIENGESELLSCHAFT | New Penicillins, their preparation and their pharmaceutical use | Details |
| P 231 | BAYER AKTIENGESELLSCHAFT | New Penicillins, their preparation and their use | Details |
| P 232 | MERCK & CO., INC. | Improved Indomethacin Suppositories | Details |
| P 233 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Pyridoquindine derivatives | Details |
| P 234 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Novel Pryimidine Sulphamates, their preparation and use | Details |
| P 235 | TUP! (PANAMA) S.A. | Food Containers | Details |
| P 236 | RHONE-POULENC S.A. | Hydantoin derivatives | Details |
| P 237 | SMITH KLINE & FRENCH LABORATORIES LIMITED | Thiourea Derivatives | Details |
| P 238 | SMITH KLINE & FRENCH LABORATORIES LIMITED | Ureas, Thioureas and Guanidines | Details |
| P 239 | PIETER ROBERT BOM | Improvements in or relating to Flash Evaporators | Details |
| P 240 | JOHN ALLAN | Rotary Piston Machines | Details |
| P 241 | F. HOFFMANN-LA ROCHE & CO., AKTIENGESELLSCHAFT | A Benzodiazepene derivative | Details |
| P 242 | FISONS LIMITED | Pharmaceutical Compositions containing Bischromonyloxy Compounds | Details |
| P 243 | FISONS LIMITED | Pharmaceutical Compositions | Details |
| P 244 | CHARLES BELPAUME | Briefs | Details |
| P 245 | TUP! (PANAMA) S.A. | Insect Swatting Device | Details |
| P 246 | TUP! (PANAMA) S.A. | Improvements in Combs | Details |
| P 247 | TUP! (PANAMA) S.A. | Massage Device | Details |
| P 248 | TUP! (PANAMA) S.A. | Grooming Implement | Details |
| P 249 | TUP! (PANAMA) S.A. | Grooming Implements | Details |
| P 250 | TUP! (PANAMA) S.A. | Portable Washing Device | Details |
| P 251 | TUP! (PANAMA) S.A. | Washing Tub | Details |
| P 252 | PHILAGRO | Herbicidal Compositions containing Isopropyl Phenyl Dimethyl Urea | Details |
| P 253 | FISONS LIMITED | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compsitions thereof | Details |
| P 254 | TUP! (PANAMA) S.A. | Automobile Passenger Restraint | Details |
| P 255 | TUP! (PANAMA) S.A. | Lids of Synthetic Plastics Material | Details |
| P 256 | WIN LIGHTER KABUSHIKI KAISHA, T/A WIN LIGHTER CORPORATION | A burner nozzle assembly for a gas lighter | Details |
| P 257 | WILKINSON SWORD LIMITED | Improvements in or relating to containers for shaving units | Details |
| P 258 | ELI LILLY AND COMPANY | Antibiotic A-4696 | Details |
| P 259 | TUP! (PANAMA) S.A. | A Nose Mask Device | Details |
| P 260 | TUP! (PANAMA) S.A. | A portable article for use in cooking and heating food and drink | Details |
| P 261 | TUP! (PANAMA) S.A. | The control of erosion | Details |
| P 262 | TUP! ( PANAMA) S.A. | Facial Wear | Details |
| P 263 | IMPERIAL GROUP LIMITED | Nicotine Fortification of Smoking Products | Details |
| P 264 | ASTRA LAKEMEDEL AKTIEBOLAG | Water Swellable Polymers and their metal complexes | Details |
| P 265 | FISONS LIMITED | Compost | Details |
| P 266 | FISONS LIMITED | Peat Wetting Agent Compositions | Details |
| P 267 | AMERICAN CYANAMID COMPANY | Melt Spinning of Refractory Polymers | Details |
| P 268 | THE WELLCOME FOUNDATION LIMITED | Pharmaceutical Formulations | Details |
| P 269 | BRITISH TECHNOLOGY GROUP LIMITED | 3-Substituted-2, 2-dimethyl-cyclopropane carboxylic acid esters, their preparation and their use in pesticidal compositions | Details |
| P 270 | THE WELLCOME FOUNDATION LIMITED | Tablet Formulation | Details |
| P 271 | AKTIEBOLAGET LEO | Buffered Smoking Substitute Compositions | Details |
| P 272 | BAYER AKTIENGESELLSCHAFT | New Penicillins, their production, and their medicinal use | Details |
| P 273 | BAYER AKTIENGESELLSCHAFT | New Penicillin compounds, their production and their medicinal use | Details |
| P 274 | GLAXO LABORATORIES LIMITED | Cephalosporin Antibiotics (Cephalosporin 189) | Details |
| P 275 | NORMAN RUDD (DAMP COURSING DIVISION) LIMITED | A method and means of damp proofing porous material | Details |
| P 276 | MERCK & CO., INC. | Antibiotics and processes for their production | Details |
| P 277 | MERCK & CO., INC. | Antihypertensive Compositions | Details |
| P 278 | COLT INTERNATIONAL LIMITED | Improvements relating to ventilators | Details |
| P 279 | COLT INTERNATIONAL LIMITED | Improvements relating to ventilators | Details |
| P 280 | COLT INTERNATIONAL LIMITED | Improvements relating to ventilators | Details |
| P 281 | COLT INTERNATIONAL LIMITED | Improvements relating to ventilators | Details |
| P 282 | COLT INTERNATIONAL LIMITED | Improvements relating to ventilators | Details |
| P 283 | ELI LILLY AND COMPANY | Dopamine Derivatives | Details |
| P 284 | NATIONAL RESEARCH DEVELOPMENT CORPORATION | Improvements in Monitoring Apparatus | Details |
| P 285 | NATIONAL RESEARCH DEVELOPMENT CORPORATION | Improvements in apparatus for monitoring the impedance between electrodes | Details |
| P 286 | E.I. DU PONT DE NEMOURS AND COMPANY | Improvements in and relating to herbicides | Details |
| P 287 | MERCK & CO., INC. | Pharmaceutical compositions | Details |
| P 288 | THOMAS EDWARD EVANS | Improved means of flow measurement and detection | Details |
| P 289 | CIBA-GEIGY (UK) LIMITED | Treatment of water to prevent the deposition of scale | Details |
| P 290 | THE BOOTS COMPANY LIMITED | Fungicidal Imidazole Derivatives | Details |
| P 291 | DAWSON & USHER LIMITED | Improvements in a method of forming wire rope strands and wire ropes produced therefrom | Details |
| P 292 | CIBA-GIEGY AG | Chloroacetanilides for regulating plant growth | Details |
| P 293 | CIBA-GEIGY AG | An N-Substituted Chloroacetanilide for regulating plant growth | Details |
| P 294 | FISONS LIMITED | Topical Compositions | Details |
| P 295 | CIBA-GEIGY AG | Substituted Amides and their use as fungicides | Details |
| P 296 | CIBA-GEIGY (UK) LIMITED | Inhibiting scale formation in aqueous systems | Details |
| P 297 | KOSAN A/S | Cultivation of palnts growing singly in a separate plant bed | Details |
| P 298 | LILLY INDUSTRIES LIMITED | Benzoxazole Derivatives | Details |
| P 299 | ELI LILLY AND COMPANY | M-Dioxane-5-Methylamine Analgesics | Details |
| P 300 | SCHERICO LIMITED | Novel Pseudotrisaccharides and methods for their production | Details |
| P 301 | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION | Improvements in and relating to feed supplements for ruminants | Details |
| P 302 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | Morpholine Derivatives | Details |
| P 303 | TOYAMA CHEMICAL CO. LTD. | Novel Penicillins and Cephalosporins and process for producing the same | Details |
| P 304 | TOYAMA CHEMICAL CO. LTD., | Amino Acid Derivatives | Details |
| P 305 | TOYAMA CHEMICAL CO. LTD. | Novel Cephalosporins and process for producing the same | Details |
| P 306 | TOYAMA CHEMICAL CO. LTD. | 2-3 Dioxopiperazine Derivatives | Details |
| P 307 | TOYAMA CHEMICAL CO. LTD | A process for producing novel Penicillins and Cephalosporins | Details |
| P 308 | MARINE DEVELOPMENT (GLASGOW) LIMITED | Loading Ramp | Details |
| P 309 | MERCK & CO., INC. | Opthalmic Compositions | Details |
| P 310 | ZENECA LIMITED | Herbicidal Compositions | Details |
| P 311 | THE WELLCOME FOUNDATION LIMITED | Purine Compounds and Salts thereof | Details |
| P 312 | RHONE-POULENC INDUSTRIES | Gelling Silicates | Details |
| P 313 | RHONE-POULENC INDUSTRIES | Gelling Silicates | Details |
| P 314 | WILKINSON SWORD LIMITED | Improvements in or relating to Shaving Units | Details |
| P 315 | DUNLOP LIMITED | Channel-like structure for Horticulture and Flower-growing | Details |
| P 316 | DUNLOP LIMITED | Channel-like structure for Horticulture and Flower-growing | Details |
| P 317 | DUNLOP LIMITED | Channel-like structure for Horticulture and Flower-growing | Details |
| P 318 | ELI LILLY AND COMPANY | 3-Halo Cephalosporins | Details |
| P 319 | ELI LILLY AND COMPANY | Vinca Alkaloid Derivatives | Details |
| P 320 | ELI LILLY AND COMPANY | Alpha-Aminoacyl-3-Halo Cephalosporins | Details |
| P 321 | DUNLOP LIMITED | Channel-like structure for Horticulture and Flower-growing | Details |
| P 322 | PITMAN-MOORE INC. | Method for Insecticide use | Details |
| P 323 | FISONS LIMITED | Pelletised Medicament Formulations | Details |
| P 324 | THE WELLCOME FOUNDATION LIMITED | Tablet Formulation | Details |
| P 325 | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION | Method and food composition for feeding ruminants | Details |
| P 326 | IMPERIAL CHEMICAL INDUSTRIES LIMITED | New Carboxylic Acid Derivatives | Details |
| P 327 | MERCK & CO. | Anitbacterial compositions | Details |
| P 328 | ALUMINIUM PECHINEY | Chemical Process | Details |
| P 329 | ALUMINIUM PECHINEY | Purification of Sulphuric Acid | Details |
| P 330 | PETER WARING LIMITED & PETER JOHN WARING | Laying flexible material | Details |
| P 331 | THE WELLCOME FOUNDATION LIMITED | Antimicrobial Preparations | Details |
| P 332 | MERCK & CO. INC. | Tripeptides and their production | Details |
| P 333 | MERCK & CO. INC. | Compositions containing Indanyloxyalkanoic Acid Compounds | Details |
| P 334 | MERCK & CO. INC. | Substituted Indanones | Details |
| P 335 | ALLEN & HANBURYS LIMITED | Aminoalkyl Furan Derivatives | Details |
| P 336 | WESTERN GEOPHYSICAL COMPANY OF AMERICA | Seismic Data Processing system and method | Details |
| P 337 | RHONE-POULENC INDUSTRIES | 1, 8-Naphthyridine Derivatives | Details |
| P 338 | MERCK & CO. INC. | Antibiotic Azetidinopyrrole Derivative | Details |
| P 339 | MERCK & CO. INC. | Pyrrolo (2,1-b) (3) Benzazepines, methods of preparing them, pharmaceutical compositions containing them, and their use for treatment of non-human animals | Details |
| P 340 | MERCK & CO. INC. | Pyrazinyl Piperazine Derivatives | Details |
| P 341 | HENRI VIDAL | Improvements in Constructional Works | Details |
| P 342 | HENRI VIDAL | Improvements in or relating to revetments | Details |
| P 343 | WILLIAM LOVE | Improvements relating to adjustable roof structures | Details |
| P 344 | RAYMOND INTERNATIONAL BUILDERS INC. | Method for erecting offshore structures and apparatus therefor | Details |
| P 345 | RAYMOND INTERNATIONAL BUILDERS INC. | Method of erecting offshore structures and offshore tower construction therefor | Details |
| P 346 | RAYMOND INTERNATIONAL BUILDERS INC. | Offshore tower construction and erection method | Details |
| P 347 | RAYMOND INTERNATIONAL BUILDERS INC. | Offshore tower constructions and erection method | Details |
| P 348 | NIPPON VICTOR KABUSHIKI KAISHA | Magnetic Tape Cassette | Details |
| P 349 | MERCK & CO. INC. | Ophthalmic Applicator | Details |
| P 350 | MERCK & CO. INC. | Hepatitis A Antigen | Details |
| P 351 | MERCK & CO. INC. | Imidazoles | Details |
| P 352 | ZENECA LIMITED | Sustained Release Pharmaceutical Composition | Details |
| P 353 | NOVO NORDISK A/S | 4-Phenylpiperdine Compounds | Details |
| P 354 | HOECHST AKTIENGESELLSCHAFT | Sulphamoylbenzoic Acid Derivatives and a process for their production | Details |
| P 355 | HOECHST AKTIENGESELLSCHAFT | Sulphamoylbenzoic Acid Derivatives and processes for preparing them | Details |
| P 356 | MERCK & CO. INC. | Cyclic Ethers | Details |
| P 357 | THAGARD TECHNOLOGY COMPANY | Fluid-Wall Reactors and their utilization in high temperature chemical reaction processes | Details |
| P 358 | IMPERIAL CHEMICAL INDUSTRIES PLC | Diphenylmethane Derivatives and pharmaceutical compositions containing them | Details |
| P 359 | IMPERIAL CHEMICAL INDUSTRIES PLC | Light-weight packages comprising a skeletal container | Details |
| P 360 | RAY MILTON DOLBY | Improvements in noise reduction systems | Details |
| P 361 | BRITISH-AMERICAN TOBACCO COMPANY LIMITED | Improvements relating to Tobacco-Smoke Filters | Details |
| P 362 | E.I. DU PONT DE NEMOURS AND COMPANY | Improvements in or relating to water-bearing explosives | Details |
| P 363 | TATE & LYLE PLC. | Sweeteners | Details |
| P 364 | SCHERING AKTIENGESELLSCHAFT | Fungicidally Active Cyclopropanecarboxylic Acid Anilides and their manufacture and use | Details |
| P 365 | SMITH KLINE & FRENCH LABORATORIES LIMITED | Pyrimidone and Thiopyrimidone Derivatives | Details |
| P 366 | GLAXO GROUP LIMITED | Cephalosporin Antibiotics | Details |
| P 367 | GLAXO OPERATIONS U.K. LIMITED | Ester Derivatives for Cefuroxime | Details |
| P 368 | JEREMY DAVID LE HARDY QUITON | Improvements in or relating to water craft | Details |
| P 369 | JAN EVERT LILJA AND SVEN ERIK LENNART NILSSON | Capillary Sampling Optical Cuvette | Details |
| P 370 | F. HOFFMAN-LA ROCHE & CO. AKTIENGESELLSCHAFT | Acyl Derivatives | Details |
| P 371 | FISONS PLC | Pressurised aerosol formulation | Details |
| P 372 | DOLBY LABORATORIES LICENSING CORPORATION | Signal Compressors and Expanders | Details |
| P 373 | DE FORENEDE BRYGGERIER A/S | A method of brewing beer of improved stability | Details |
| P 374 | CONCRETE UTILITIES LIMITED | Locking mechanism for hinged lighting column | Details |
| P 375 | SANOFI | Novel derivatives of glycerin, their preparation and pharmaceutical compositions containing them | Details |
| P 376 | AKTIEBOLAGET DRACO. | Ethanolamine compounds, processes for their preparation, pharmaceutical preparations containing them and their medicinal use | Details |
| P 377 | ZENECA LIMITED | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof, and process for their manufacture | Details |
| P 378 | ZENECA LIMITED | Herbicidal Pyridine compounds and herbicidal compositions containing them | Details |
| P 379 | AKTIEBOLAGET DRACO. | An aerosol inhalation device | Details |
| P 380 | FBC LIMITED | Acaricidal, larvicidal and ovicidal tetrazine derivatives and compositions, processes for their preparation and methods of using them | Details |
| P 381 | SMITH KLINE & FRENCH LABORATORIES LIMITED | Pyrimidone and thiopyrimidone derivatives | Details |
| P 382 | S.A. LABAZ-SANOFI N.V. | Indolizine derivatives and their manufacture | Details |
| P 383 | PITMAN-MOORE INC. | Antibiotic M 139,603 from Streptomyces longisporoflavus | Details |
| P 384 | AKTIEBOLAGET DRACO. | Therapeutically active derivatives of Phenylethanol Amines | Details |
| P 385 | SMITHKLINE BECKMAN CORPORATION | Benzazepines | Details |
| P 386 | TAISHO PHARMACEUTICAL CO. LTD. | Hydrocortisone Derivative | Details |
| P 387 | AKTIEBOLAGET DRACO. | 1-(Dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates | Details |
| P 388 | YAMANOUCHI PHARMACEUTICAL COMPANY LIMITED | 7x-methoxy-7b - (1,3-dithietane-2-carboxamido) cephalosporanic acid derivatives | Details |
| P 389 | FISONS PLC | Pyranoquinolinones | Details |
| P 390 | F. HOFFMAN-LA ROCHE & CO. AKTIENGESELLSCHAFT | Stilbene Derivatives | Details |
| P 391 | HENRY WILD | Compositions for the relief of migraine | Details |
| P 392 | PLEDGE OFFICE CHAIRS LIMITED | A Tilting Mechanism for a Chair | Details |
| P 393 | AKTIEBOLAGET HASSLE | 2,6 Dimethyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid-3-methyl ester-5-ethyl ester having hypotensive properties, process for its preparation and pharmaceutical preparations containing it | Details |
| P 394 | GEC PLESSEY TELECOMMUNICATIONS LIMITED | Time Division Multiplex Telecommunication Digital Switching Module | Details |
| P 395B | THE PLESSEY COMPANY PLC | Improvements in or relating to integrated light detecting or generating means and amplifying means | Details |
| P 396 | GLAXO GROUP LIMITED | Androstane Carbothioates | Details |
| P 397 | FISONS PLC | Nitrogen and Oxygen containing Heterocyclic compounds | Details |
| P 398 | GLAXO GROUP LIMITED | Aminoalkyl Furan Derivative | Details |
| P 399 | GLAXO GROUP LIMITED | A device for dispensing medicaments | Details |
| P 400 | TAISHO PHARMACEUTICAL CO. LTD | Novel Erythromycin Compounds | Details |
| P 401 | AKTIEBOLAGET HASSLE | Pyridine Derivatives | Details |
| P 402 | MILES LABORATORIES INC. | 17-Cycloalkylmethyl-6-methylene-morphinane-derivatives | Details |
| P 403 | FISONS PLC | Biologically active mixtures and slats of heterocyclic compounds | Details |
| P 404 | GLAXO GROUP LIMITED | Heterocyclic derivatives | Details |
| P 405 | GLAXO GROUP LIMITED | Improvements in or relating to a cephaloporin antibiotic | Details |
| P 406 | GENENTECH INC. | Human tissue plasminogen activator, pharmaceutical compositions containing it, processes for making it, and DNA and transformed cell intermediates therefor | Details |
| P 407 | THE VICTORIA UNIVERSITY OF MANCHESTER | A device for detecting the presence of air in a steam steriliser | Details |
| P 408 | SUPER-PIPE INTERNATIONAL CORP. (LIBERIA) | A method of manufacture of a composite metal-plastic tube and equipment for implementing the same | Details |
| P 409 | MERCK & CO. INC. | Antibacterial composition of Thienamycin type compound and a Dipeptidase inhibitor | Details |
| P 410 | MERCK & CO. INC. | Carboxyalkyl Dipeptide derivatives, process for preparing them and pharmaceutical composition containing them | Details |
| P 411 | THE PLESSEY COMPANY PLC | Coin Runway with coin sequencing facility | Details |
| P 412 | STC PLC | Electroninc Telephone Circuit | Details |
| P 413 | STC PLC | A push-button electrical switch arrangement | Details |
| P 414 | ALBRIGHT & WILSON LIMITED | Pourable fluid detergent compositions | Details |
| P 415 | HAROLD J BEARD | Clarifier for removing solids from waste water | Details |
| P 416 | JOHN A KITCHEN | Pulse combustion apparatus | Details |
| P 417 | BP CHEMICAL LIMITED | Use of formate esters in dyeing and/or printing processes | Details |
| P 418 | YAIR DAAR AND SHIMON YAHAV | Hair removal | Details |
| P 419 | GLAXO GROUP LIMITED | Pharmaceutical compositions | Details |
| P 420 | MERCK & CO. INC. | 6(R)-(2-(8'-Acyloxy-2'-Methyl-6'-Methyl(or Hydrogen)-Polhydronaphthyl-1')-Ethyl)-4(R)-Hydroxy-3,4,5,6,-Tetrahydro-2H-Pyran-2-Ones, The Hydroxy Acid form of said Pyranones, the pharmaceutically acceptable salts of said Hydroxy Acids, and the lower Alkyl, and Phenyl, Dimethylamino or Acetylamino substituted lower Alkyl Esters of said Hydroxy Acid, processes for preparing the same, and a pharmaceutical antihypercholesterolemic compostions containing the same | Details |
| P 421 | RHONE-POULENEC AGROCHIMIE | Fungicidal compositions based on iprodione | Details |
| P 422 | F. HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT | Tetrahydronaphthalene and Indan compounds, their production and pharmaceutical preparations | Details |
| P 423 | MERCK & CO. INC. | Waterless thixotropic composition | Details |
| P 424 | THE LISTER INSTITUTE OF PREVENTIVE MEDICINE | Polynucleotide Probes | Details |
| P 425 | BRITISH-AMERICAN TOBACCO COMPANY LIMITED | Improvements relating to Hinged-Lid packets | Details |
| P 426 | RHONE-POULENC AGRICULTURE LIMITED | New herbicidal nicotinamide derivatives | Details |
| P 427 | GLAXO GROUP LIMITED | Novel form cefuroxime ester, process for its preparation and compositions containing it | Details |
| P 428 | FISONS PLC | Amine derivatives, processes for their production and pharmaceutical compsitions containing them | Details |
| P 429 | G-STONE LIMITED | Retaining Wall | Details |
| P 430 | JANSSEN PHARMACEUTICA NV | Novel N - (3-Hydroxy-4-Piperidinyl) - Benzamide Derivatives | Details |
| P 431 | JANSSEN PHARMACEUTICA NV | Novel 1 - (Cyclohexyl or Cyclohexenyl) 4-Aryl-4-Piperidine Carboxylic Acid Derivatives | Details |
| P 432 | ROBERT FRANKLIN WILSON | Golf game simulating apparatus | Details |
| P 433 | IMPERIAL CHEMICAL INDUSTRIES PLC | 1, 3-Dioxan-5-ylalkenoic acids | Details |
| P 434 | BRISTOL-MYERS COMPANY | Chemical compounds derived from Cyclobutene | Details |
| P 435 | BRISTOL-MYERS COMPANY | Chemical intermediates derived from Cyclobutene | Details |
| P 436 | GLAXO GROUP LIMITED | Indoles | Details |
| P 437 | FRICTIONLESS HINGES & JOINTS LIMITED | Improvements in and relating to hinges | Details |
| P 438 | GENENTECH INC | Preparation of polypeptides in vertebrate cell culture | Details |
| P 439 | GLAXO GROUP LIMITED | An indole derivative | Details |
| P 440 | GLAXO GROUP LIMITED | 1,2,3,9-Tetrahydro-3-(imidazol-1-ylmethyl)-4H-carbazol-4-one derivatives | Details |
| P 441 | GLAXO GROUP LIMITED | Medicament-containing pack | Details |
| P 442 | ORION-YHTYMA OY | An antibiotic compound, a method for its preparation, and compositions containing it | Details |
| P 443 | GLAXO GROUP LIMITED | Phenethanolamine Derivatives | Details |
| P 444 | GLAXO GROUP LIMITED | Devices for administering medicaments to patients | Details |
| P 445 | GLAXO GROUP LIMITED | Devices for administering medicaments to patients | Details |
| P 446 | BRITISH-AMERICAN TOBACCO COMPANY LIMITED | Improvements relating to smoking articles | Details |
| P 447 | GLAXO GROUP LIMITED | Piperidinylcyclopentanol heptenoic acid salt | Details |
| P 448 | THAMES WATER AUTHORITY | A process for thickening digested sludge | Details |
| P 449 | JON LIE | Individual parking meter | Details |
| P 450 | GLAXO GROUP LIMITED | Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation | Details |
| P 451 | AKTIEBOLAGET DRACO | Powder Inhalator | Details |
| P 452 | RHONE-POULENC AGROCHIMIE | Fungicidal composition based on Aluminium Tris- (ethyl phosphate) | Details |
| P 453 | GLAXO SPA | 4-aryl-1, -4-dihydropyridine-3, 5-dicaboxylate derivatives | Details |
| P 454 | BRITISH TECHNOLOGY GROUP LIMITED | Pharmaceutical compositions | Details |
| P 455 | BRITISH TECHNOLOGY GROUP LIMITED | Pharmaceutical compositions containing a complex of iron with N-substituted 3-Hydroxypyrid-2-one or -4-one derivatives | Details |
| P 456 | BRITISH TECHNOLOGY GROUP LIMITED | Iron Complexes of 3-Hydroxypyrid-2-and-4-ones | Details |
| P 457 | BRITISH TECHNOLOGY GROUP LIMITED | Pharmaceutical compositions containing N-substituted -3-Hydroxypirid-2-one or -4-one derivatives | Details |
| P 458 | SMITHKLINE BECKMAN CORPORATION | 4-Aminoalky-2(3H)-Indolones | Details |
| P 459 | ORTHO PHARMACEUTICAL (CANADA) LTD | Streamlined T-shapted intrauterine device and method of preventing conception | Details |
| P 460 | SMITH KLINE & FRENCH LABORATORIES LIMITED | Dosage Units | Details |
| P 461 | GLAXO GROUP LIMITED | Improvements in or relating to a steroid compound and pharmaceutical composition containing it | Details |
| P 462 | BRITISH TECHNOLOGY GROUP LIMITED | 3-Hydroxypyrid-2-and-4-ones | Details |
| P 463 | IMPERIAL CHEMICAL INDUSTRIES PLC | Amide derivatives, processes for preparing them, their use as fungicides and pesticidal compositions containing them | Details |
| P 464 | BRITISH TECHNOLOGY GROUP LIMITED | Poly(Hydroxypyridone) compounds | Details |
| P 465 | IAN MALCOLM ROBERTSON | Wood preservation | Details |
| P 466 | GLAXO GROUP LIMITED | Benzodioxinopyrroles | Details |
| P 467 | GEC AVERY LIMITED | Metering devices and magnetic cards for use with such devices | Details |
| P 468 | GEC AVERY LIMITED | Metering devices and magnetic cards for use with such devices | Details |
| P 469 | VERHO-METALLI OY | A method of and a press for bending of profiled sheet metal | Details |
| P 470 | MERCK & CO. INC. | 17 Beta-substituted-4-Aza-5-Alpha-Androstenones and their use as 5-Alpha-Reductase inhibitors | Details |
| P 471 | MERCK & CO. INC. | Hexahydronaphth(1,2-b)-1,4-Oxazines, process for their preparation and pharmaceutical formulation containing them | Details |
| P 472 | GLAXO SPA | 4-Phenyl-dihydropyridine carboxylic acid derivatives | Details |
| P 473 | IMPERIAL CHEMICAL INDUSTRIES PLC | Herbicidal pyridine compounds and herbicidal compositions containing them | Details |
| P 474 | THE WELLCOME FOUNDATION LIMITED | Naphthoquinone derivatives | Details |
| P 475 | GLAXO GROUP LIMITED | Indole derivatives | Details |
| P 476 | GLAXO GROUP LIMITED | Film coated cefuroxime axetil tablets | Details |
| P 477 | GLAXO GROUP LIMITED | Cephalosporin antibiotics | Details |
| P 478 | MERCK & CO. INC. | Process for C-Methylation of 2-Methybutyrates | Details |
| P 479 | BRITISH TECHNOLOGY GROUP LIMITED | Pharmaceutical compositions containing 1-Hydroxypyrid-2-One derivatives | Details |
| P 480 | BRITISH TECHNOLOGY GROUP LIMITED | Iron complexes | Details |
| P 481 | MERCK & CO. INC. | Antiparasitic non-aqueous formulation containing an avermectin or milbemycin | Details |
| P 482 | ICI AUSTRALIA LIMITED | Herbical cyclohexane-1,3 dione derivatives | Details |
| P 483 | MERCK SHARP & DOHME LTD | Stabilization of unstable drugs of food supplements | Details |
| P 484 | BIOGEN, INC. | Recombinant DNA, hosts transformed with it and polypeptides produced by the hosts; processes for their preparations; detection processes using the polypeptides; compositions and means containing the polypeptides; DNA sequences | Details |
| P 485 | BIOGEN, INC. | Recombinant DNA molecules and their method of production (see file for certificate of supplementary protection prepared by LC and accompanying letter dated 14 August 2000) | Details |
| P 486 | JANSSEN PHARMACEUTICA N.V. | Derivatives of 2,2'-iminobisethanol | Details |
| P 487 | JANSSEN PHARMACEUTICA N.V. | Novel ((bis(aryl)methylene)-1-piperidinyl)alkyl-pyrimidinones | Details |
| P 488 | JANSSEN PHARMACEUTICA N.V. | Novel Alpha, Alpha-Diaryl-4-Aryl-4-Hydroxy-1-Piperidinebutanamide, N-Oxides | Details |
| P 489 | JANSSEN PHARMACEUTICA N.V. | 1-(2-aryl-2-halo-1-ethenyl)-1H-azoles | Details |
| P 490 | C/S CONSTRUCTION SPECIALITIES LIMITED | Concrete Floor Panel and Floor System | Details |
| P 491 | GLAXO GROUP LIMITED | Pharmaceutical composition | Details |
| P 492 | BAR ILAN UNIVERSITY | Physiologically active and nutritional composition | Details |
| P 493 | MERCK & CO. INC. | 13 - substituted derivatives of Avermectin Aglycones | Details |
| P 494 | THE WELLCOME FOUNDATION LIMITED | Anitviral Nucleosides | Details |
| P 495 | VENTROLLA LIMITED | The reduction of draughts through sliding sash windows | Details |
| P 496 | AKTIEBOLAGET HASSLE | Controlled release metoprolol preparations | Details |
| P 497 | WARNER-LAMBERT COMPANY | Aromatic compounds | Details |
| P 498 | GLAXO GROUP LIMITED | Medicaments for the treatment of Emesis | Details |
| P 499 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA/ WASHINGTON RESEARCH FOUNDATION | Synthasis of human virus antigens by yeast | Details |
| P 500 | LABORATOIRES GLAXO S.A. | Pharmaceutical compositions | Details |
| P 501 | MERCK & CO. INC. | Tamper evident overcap | Details |
| P 502 | WYRE PLASTERERS & BUILDERS LIMITED | A coating material | Details |
| P 503 | GLAXO GROUP LIMITED | Ranitidine derivatives | Details |
| P 504 | GLAXO GROUP LIMITED | Dichloroaniline derivatives | Details |
| P 505 | JOHNSON & JOHNSON | Silicone gel coated permeable wound dressing | Details |
| P 506 | MERCK & CO. INC. | Process for resolution and race mization of amines with acidic alpha-hydrogens | Details |
| P 507 | MERCK & CO. INC. | Controlled porosity osmotic pump | Details |
| P 508 | BRITISH TECHNOLOGY GROUP LTD | Moulding process | Details |
| P 509 | KIRIN-AMGEN, INC. | Production of Erythropoietin | Details |
| P 510 | KIRIN-AMGEN, INC. | Production of Pluripotent Granulocyte Colony-stimulating factor | Details |
| P 511 | NATIONAL RESEARCH DEVELOPMENT CORPORATION | Pharmaceutical compositions | Details |
| P 512 | THE WELLCOME FOUNDATION LIMITED & THE GENERAL HOSPITAL CORPORATION | Bis-Dimethoxymethyl (Trimethoxybenzyl) Isoquinolinium Salts, their preparation and pharmaceutical compositions containing them | Details |
| P 513 | FISONS PLC | Pharmaceutical formulation | Details |
| P 514 | BOIVITRUM AB | Biologically Active Fragmetns of the human antihemophilic factor and method for their preparation and pharmaceutical preparations | Details |
| P 515 | GLAXO GROUP LIMITED | Use of Ketone derivatives in the treatment of cognitive disorders | Details |
| P 516 | GLAXO GROUP LIMITED | Use of Ketone derivatives in the treatment of depression | Details |
| P 517 | GLAXO GROUP LIMITED | Ketone derivatives as medicaments for the treatment or prevention of the withdrawal syndrome | Details |
| P 518 | GLAXO GROUP LIMITED | Heterocyclic Akino compounds | Details |
| P 519 | BRITISH TECHNOLOGY GROUP LTD | Improvements in or relating to methods and apparatus for the continuous formation of an extruded product | Details |
| P 520 | SOLETANCHE | Motoric device for digging trenches in the soil with the aid of rotary cutters | Details |
| P 521 | ROBERT FINKE GMBH & CO KG | Bottle sealing cap for two component containers | Details |
| P 522 | SOLETANCHE | A motor driven pump for a milling action cutting machine for the digging of trenches in the ground | Details |
| P 523 | SOLETANCHE | Process for the maintenance of side partitions of deep excavations | Details |
| P 524 | SOLETANCHE SOCIETE ANONYME | Process for resorbing liquid leaks | Details |
| P 525 | SOLETANCHE SOCIETE ANONYME | Attachment means for the power units of a milling device for digging soil trenches | Details |
| P 526 | SOLETANCHE SOCIETE ANONYME | Process for making soils impervious and products for carrying out this process | Details |
| P 527 | MERCK & CO. INC. | Oxidized analogs of 17 Beta-N-Monosubstituted Carbamoyl-4-aza 5 Aplha-Androst-1-En-3-Ones | Details |
| P 528 | MERCK & CO. INC. | Controlled Porosity Osmotic Pump | Details |
| P 529 | GLAXO GROUP LIMITED | Indole derivatives | Details |
| P 530 | ASTRA AKTIEBOLAG | 2-Aminoacetamide derivatives | Details |
| P 531 | GLAXO CANADA INC. | Pharmaceutical capsules containing rantidine | Details |
| P 532 | WINSTON THOMAS PATRICK WRIGHT | Hull Cleaning Apparatus | Details |
| P 533 | BRITISH-AMERICAN TOBACCO COMPANY LIMITED | Improvements relating to smoking articles | Details |
| P 534 | BRITISH-AMERICAN TOBACCO COMPANY LIMITED | Improvements relating to smoking articles | Details |
| P 535 | KRUPP VDM GMBH | Composite layered material for the manufacture of coins | Details |
| P 536 | AKTIEBOLAGET HASSLE | new drug preparation with controlled release of the active compound, and a method for the manufacture thereof | Details |
| P 537 | NOVARTIS AG | Pesticide | Details |
| P 538 | NOVARTIS AG | Quinoline derivatives for the protection of crop plants | Details |
| P 539 | NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD | Purine derivatives and their pharmaceutical use | Details |
| P 540 | GLAXO GROUP LIMITED | Lactam derivatives | Details |
| P 542 | GPT LIMITED | Optical fibre storage apparatus | Details |
| P 543 | GPT LIMITED | Optical transmission apparatus | Details |
| P 544 | GPT LIMITED | Power systems for telephony systems | Details |
| P 545 | GPT LIMITED | Fibre optical connector | Details |
| P 546 | GPT LIMITED | Improvements in or relating to electric oscillator circuit arrangements | Details |
| P 547 | GPT LIMITED | Housing arrangements for electrical or electronic equipment | Details |
| P 548 | GPT LIMITED | PCM communication system | Details |
| P 549 | GPT LIMITED | PCM communication system | Details |
| P 550 | GPT LIMITED | TDM data transmission system | Details |
| P 551 | GPT LIMITED | Data path protection | Details |
| P 552 | GPT LIMITED | Transmission systems | Details |
| P 553 | GPT LIMITED | Improvements in or relating to digital data signalling systems and apparatus therefor | Details |
| P 554 | GPT LIMITED | Optical FSK demodulator | Details |
| P 555 | GLAXO GROUP LIMITED | Ranitidine resin adsorbates | Details |
| P 556 | NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD | Antiviral guanine derivatives | Details |
| P 557 | YAN YIN-LUNG | Road junctions | Details |
| P 558 | AKTIEBOLAGET DRACO | Device in powder inhalators | Details |
| P 559 | GLAXO GROUP LIMITED | Inhalation medicaments for treating respiratory disorders | Details |
| P 560 | AKTIEBOLAGET HASSLE | Solid pharmaceutical preparations with extendet release and process for its preparations | Details |
| P 561 | THE WELLCOME FOUNDATION LIMITED | Therapeutic Nucleosides | Details |
| P 562 | ESCALATOR ADVERTISING LIMITED | Advertising fitting | Details |
| P 563 | SECURISTYLE LIMITED | Window restricting device | Details |
| P 564 | ZENECA INC. | Thiazepine compounds | Details |
| P 565 | ZENECA INC. | Heterocyclic Amide derivatives | Details |
| P 566 | THE WELLCOME FOUNDATION LIMITED | Naphthoquinones for the treatment and prophylaxis of Pneumocystis Carinii infections | Details |
| P 567 | THE WELLCOME FOUNDATION LIMITED | Improvements in or relating to Antiprotozoal agents | Details |
| P 568 | SOLAGLAS LIMITED | Improvements in cladding | Details |
| P 569 | NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD | Derivatives of penciclovir for the treatment of hepatitis - B infections | Details |
| P 570 | EXQUISITE ACQUISITION, INC. | Bra with underarm comfort feature | Details |
| P 571 | MARKS UK LIMITED | A 21kD protein from the cocoa bean and the 23kD precursor thereof | Details |
| P 572 | MARS UK LIMITED | 47kD and 31kD cocoa bean proteins and a 67 kD presursor therefor | Details |
| P 573 | THE DOW CHEMICAL COMPANY | Macrocyclic Aminophosphonic Acid complexes, their preparation, formulations and use | Details |
| P 574 | THE DOW CHEMICAL COMPANY | Organic Amine Phosphonic Acid compleses for the treatment of calcific tumors | Details |
| P 575 | BRIDISCO LIMITED | Electric Power Cables and process for their manufacture | Details |
| P 576 | SMITHKLINE BEECHAM PLC | Clavulanic acid preparation via certain polyamines | Details |
| P 577 | NORTON HEALTHCARE LIMITED | Medicament Dispensing Device | Details |
| P 578 | THE DOW CHEMICAL COMPANY | Radiopharmaceutical formulations, their method of administration and process of preparation | Details |
| P 579 | MERCK SHARP & DOHME CORP. | Crystalline 4-amino-1-hydroxybutylidene-1, 1-bisphosponic acid monosodium trihydrate, process therefor and compositions and use thereof | Details |
| P 580 | PSA CORPORATION LIMITED | A container code verification apparatus | Details |
| P 581 | BEACH MANAGEMENT SYSTEMS, DANMARK A/S | A method of causing sedimentation of solid material transported in a body of water, such as a lake, a sea, or an ocean | Details |
| P 582 | CENTRAL SYDNEY AREA HEALTH SERVICE | Acid-labile subunit (ALS) of Insulin-like-growth factor (IGF) binding protein complex | Details |
| P 583 | SMITH KLINE & FRENCH LABORATORIES LIMITED | Improved process for the preparation of substituted indolone derivatives | Details |
| P 584 | THE WELLCOME FOUNDATION LIMITED | Neuromuscular Blocking Agents | Details |
| P 585 | NOVARTIS INTERNATIONAL PHARMACEUTICALS LTD | Pharmaceutical formulation containing penciclovir | Details |
| P 586 | GLAXO GROUP LIMITED | Pharmaceutical compositions containing furan derivatives | Details |
| P 587 | IMUTRAN LIMITED | Modified biological material | Details |
| P 588 | SHIRE CANADA INC. | Substituted 1, 3-oxathiolanes with antiviral properties | Details |
| P 589 | NORTON HEALTHCARE LIMITED | Powdered medicament dispensing device | Details |
| P 590 | BEECHAM GROUP PLC | Process for preparing aryl-piperidine carbinols | Details |
| P 591 | THE WELLCOME FOUNDATION | Therapeutic Nucleosides | Details |
| P 592 | CONCRETE REPAIRS LTD | Realkalization and dechlorination of concrete by surface mounted electrochemical means | Details |
| P 593 | GLAXO GROUP LIMITED | Benzenedimethanol suitable for micronisation | Details |
| P 594 | OTSUKA PHARMACEUTICAL CO. LTD | 7-Piperazinyl-or 7-Morpholino-4-Oxo-Quinoline-3-Carboxylic Acid derivatives, their preparation and their use as antimicrobial agents | Details |
| P 595 | THE WELLCOME FOUNDATION LIMITED | Antiviral pyrimidine and purine compounds, process for their preparation and pharmaceutical compositions containing them | Details |
| P 596 | GLAXO GROUP LIMITED | Antiviral combinations containing nucleoside analogs | Details |
| P 597 | LABORATOIRES GLAXO S.A. | 5-HT - receptor agonist for rectal administration | Details |
| P 598 | CEPHALON INC | A modafinil composition of defined particle size | Details |
| P 599 | GLAXO GROUP LIMITED | Film coated solid dosage form of anti-migraine drug | Details |
| P 600 | FORCE TECHNOLOGY | Electrode structure | Details |
| P 601 | GLAXO GROUP LIMITED | Medicaments for treating gastrointestinal disorders | Details |
| P 602 | LIFE TECHNOLOGIES, INC. | Process for controlling contamination of oligonucleotide-dependent nucleic acid amplification reactions | Details |
| P 603 | GLAXO GROUP LIMITED | 3-(2-(dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulphonamide sulphate (2:1) | Details |
| P 604 | BIOTA SCIENTIFIC MANAGEMENT PTY LTD. | Derivatives and analogues of 2-Deoxy-2, 3-Didehydro-N-Acetyl Neuraminic acid and their use as antiviral agents | Details |
| P 605 | ASTRAZENECA AB, S-151 85 SODERTALJE, SWEDEN previously ZENECA LTD | Pharmaceutical compositions containing benzenesulphonamides | Details |
| P 606 | MERCK SHARP & DOHME CORP. | Method of treating androgenic alopecia with 5-alpha reductase inhibitors | Details |
| P 607 | BIOTA SCIENTIFIC MANAGEMENT PTY. LTD | Synthesis of N-Acetyl Neuraminic acid derivatives | Details |
| P 608 | ASTRAZENECA AB | Therapeutic Heterocyclic Compounds | Details |
| P 609 | GLAXO SPA | Indole derivatives | Details |
| P 610 | MERCK FROSST CANADA INC. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists | Details |
| P 611 | PFIZER LIMITED | Pyrazolopyrimidinones for the treatment of impotence | Details |
| P 612 | HEPWORTH BUILDING PRODUCTS LIMITED | Piping | Details |
| P 613 | MERCK FROSST CANADA INC. | Phenyl Heterocycles as Cyclooxygenase-2 inhibitors | Details |
| P 614 | NORWEB PLC | Transmission network | Details |
| P 615 | MARJORIE ANNE MOYSE | Magnifying spectacles | Details |
| P 616 | NORWEB PLC | Transmission network and filter therefor | Details |
| P 617 | ROBINSONS SOFT DRINKS LIMITED | Improvements in or relating to beverages | Details |
| P 618 | ROBINSONS SOFT DRINKS LIMITED | Improvements in or relating to beverages | Details |
| P 619 | BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. | Process for the preparation of Nl-Acetyl Neuraminic Acid Derivatives | Details |
| P 620 | GLAXO GROUP LIMITED | Use of a tetrahydrocarbazolone derivative for the manufacture of medicaments | Details |
| P 621 | ABBEYCREST PLC | Improvements relating to items of jewellery | Details |
| P 622 | BTG INTERNATIONAL LIMITED | Detection of multiple articles | Details |
| P 623 | WARNER-LAMBERT COMPANY | Stable oral CI-981 formulation and process of preparing same | Details |
| P 624 | ALI GURYEL | Attendance registration system by radio link | Details |
| P 625 | THE WELLCOME FOUNDATION LIMITED | Antiviral Compounds | Details |
| P 626 | GLAXO GROUP LIMITED | Medicaments | Details |
| P 627 | THE WELLCOME FOUNDATION LIMITED | Pharmacologically active CNS compounds | Details |
| P 628 | SMITHKLINE BEECHAM PLC | Substituted thiazolidinedione derivatives | Details |
| P 629 | TELPARK (UK) LIMITED | A Ticketing System | Details |
| P 630 | THE WELLCOME FOUNDATION LIMITED | Sustained release tablets containing Bupropion | Details |
| P 631 | THE WELLCOME FOUNDATION | Therapeutic Nucleosides | Details |
| P 632 | SMITHKLINE BEECHAM PLC | Paroxetine hudrochloride anhydrate substantially free of bound organic solvent | Details |
| P 633 | BEECHAM GROUP PLC | Substituted thiazolidinedione derivatives | Details |
| P 634 | VERTEX PHARMACEUTICALS INCORPORATED | Sulfonamide inhibitors of HIV-aspartyl protease | Details |
| P 635 | CEPHALON INC. | MODAFINIL HAVING DEFINED PARTICLE SIZE | Details |
| P 636 | THE WELCOME FOUNDATION | HETEROCYCLIC COMPOUNDS | Details |
| P 637 | NOVARTIS AG | FREEZE-DRIED DOSAGE FORM CONTAINING ONDASETRON | Details |
| P 638 | NOVARTIS AG | (postponed from 1 August due to incorrect publishing in JEP) LIQUID COMPOSITION CONTAINING ONDANSETRON | Details |
| P 639 | Merck & Co., Inc. | an invention for Antiprotozoal cyclic tetrapeptides | Details |
| P 640B | Laboratoires Glaxo SA | Ondansetron for rectal administration | Details |
| P 641 | The Wellcome Foundation Limited | Water-dispersible tablet containing Lamotrigine | Details |
| P 642 | The Wellcome Foundation Limited | VALACICLOVIR TABLET containing colloidal silicon dioxide | Details |
| P 643 | THE WELLCOME FOUNDATION LIMITED | combination of atovaquone with proguanil for the treatment of protozoal infections | Details |
| P 644 | Godecke Aktiengesellschaft | Process for the stabilisation of a solid pharmaceutical composition comprising cyclic amino acids | Details |
| P 645 | GLAXO WELLCOME INC. | Invention for Androstenone derivative | Details |
| P 646 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids | Details |
| P 647 | AstraZeneca AB | REGISTRATION 7-(2-Aminoethyl) - Benzothiazolones | Details |
| P 648 | CEPHALON INC | Modafinil having defined particle size | Details |
| P 649 | AVENTIS CROPSCIENCE SA | Derivative of a N-phenylpyrazole | Details |
| P 650 | Shionogi Seiyaku Kabushiki Kaisha | PYRIMIDINE DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS | Details |
| P 651 | Glaxo Wellcome SpA | Benzodiazepine derivatives and their use in medicine | Details |
| P 653 | ASTRAZENECA AB | Benzothiazolone Derivatives | Details |
| P 652 | Astrazeneca AB | Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics. | Details |
| P 654 | The Wellcome Foundation Limited | Use of Triazine Compounds as Anxiolytics | Details |
| P 655 | G.D. Searle & Co | Substituted Pyrazolyl Benzenesulfonamides for the treatment of Inflammation | Details |
| P 656 | Merck Sharp & Dohme Corp. | Hydroxy-Substituted Azetidinone Compounds Useful As Hypocholesterolemic Agents | Details |
| P 657 | Glaxo Group Limited | Carbocyclic nucleoside hemisulfate and its use in treating viral infections | Details |
| P 658 | Glaxo Group Limited | Nitric Oxide Synthase Inhibitors | Details |
| P 659 | The Wellcome Foundation | Hypolipidaemic Benzothiazepine Compounds | Details |
| P 660 | The Wellcome Foundation Limited | Amidino Derivatives and their use as Nitric Oxide Synthase Inhibitors | Details |
| P 661 | MERCK & CO., INC | Method for inhibiting bone resorption | Details |
| P 662 | BIOTA SCIENTIFIC MANAGEMENT PTY, LTD | Crystalline N-Acetyl Neuraminic Acid Derivatives and Processes for their preparation | Details |
| P 663 | Merck Sharp & Dohme Corp. | Sugar-Substituted 2-Azetidinones useful as Hypocholesterolemic agents | Details |
| P 664 | Kirin Amgen Inc | Erythropoietin analogs | Details |
| P 665 | Glaxo Wellcome Australia Limited | Fluticasone Propionate Formulations | Details |
| P 666 | The Wellcome Foundation Limited | Use of 3,5-Diamino-6-(2,3-Dichlorophenyl)-1,2,4-Triazine for the preparation of a medicament for the treatment of certain types of pain and of oedema | Details |
| P 667 | VERTEX PHARMACEUTICALS INCORPORATED | THF-Containing Sulfonamide Inhibitors of Aspartyl Protease | Details |
| P 668 | MERCK & CO., INC | Oral Liquid Alendronate Formulations | Details |
| P 669 | BREUNING JORGEN ILLNER | Plane hollow reinforced concrete floor with two-dimensional structure | Details |
| P 670 | ATRAVERDA LIMITED | Electrochemical method and electrode | Details |
| P 671 | WARNER-LAMBERT COMPANY | Novel process for the production of Amorphous [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1) | Details |
| P 672 | WARNER-LAMBERT COMPANY | Form III Crystalline [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta-Delta-Dihydroxy-5-(1-Methyl-Ethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Hemi Calcium Salt (Atorvastatin) | Details |
| P 673 | WARNER-LAMBERT COMPANY | Crystalline [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Hemi Calcium Salt (Atorvastatin) | Details |
| P 674 | WARNER-LAMBERT COMPANY | (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof | Details |
| P 675 | ASTRAZENECA AB | Magnesium Omeprazole | Details |
| P 676 | ATRAVERDA LIMITED | Electrochemical treatment of reinforced concrete | Details |
| P 677 | AstraZeneca AB | Crystalline forms of EtO2C-CH2-(R)Cgl-Aze-Pab-OH | Details |
| P 678 | AstraZeneca AB | Pyridazino Quinoline Compounds | Details |
| P 679 | AstraZeneca AB | Prodrugs of Thrombin inhibitors | Details |
| P 680 | Merck Canada Inc. | Substitued Pyridines as selective Cyclooxygenase-2 inhibitors | Details |
| P 681 | AstraZeneca AB | NEW 3-ARYL-2-HYDROXYPROPIONIC ACID DERIVATIVE (I) | Details |
| P 682 | AstraZeneca AB | N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS | Details |
| P 683 | AstraZeneca AB | METHOD FOR THE SYNTHESIS OF A BENZIMIDAZOLE COMPOUND | Details |
| P 684 | ALUMASC LIMITED | SLOT DRAIN | Details |
| P 685 | Ventrolla Limited | Sliding Sash Windows | Details |
| P 686 | Ventrolla Limited | Sash Window Parting Beads | Details |
| P 687 | Ventrolla Limited | Cord locking devices and sash window parting beads | Details |
| P 688 | FORTERRA BUILDING PRODUCTS LIMITED | Paving Block | Details |
| P 689 | AstraZeneca AB | PROCESS FOR PREPARING A PHARMACEUTICAL FORMULATION | Details |
| P 690 | AstraZeneca AB | THE PREPARATION OF A MAGNESIUM SALT OF A SUBSTITUTED SULPHINYL HETEROCYCLE | Details |
| P 691 | Merck Sharp & Dohme Corp. | SUGAR-SUBSTITUTED 2-AZETIDINONES USEFUL AS HYPOCHOLESTEROLEMIC AGENTS | Details |
| P 692 | AstraZeneca AB | FORMULATION | Details |
| P 693 | Farrow System Limited | A METHOD OF REMOVING SURFACE COATINGS | Details |
| P 694 | Seiko Epson Corporation | INK CARTRIDGE FOR INK-JET PRINTING APPARATUS | Details |
| P 695 | Seiko Epson Corporation | INK TANK CARTRIDGE AND CONTAINER THEREFOR | Details |
| P 696 | Seiko Epson Corporation | INK TANK CARTRIDGE AND CONTAINER THEREFOR | Details |
| P 697 | Seiko Epson Corporation | INK TANK CARTRIDGE AND CONTAINER THEREFOR | Details |
| P 698 | Seiko Epson Corporation | INK CARTRIDGE FOR INK-JET PRINTING APPARATUS | Details |
| P 699 | Seiko Epson Corporation | INK CARTRIDGE AND RECORDING APPARATUS | Details |
| P 700 | Seiko Epson Corporation | INK CARTRIDGE AND RECORDING APPARATUS | Details |
| P 701 | TEVA PHARMACEUTICAL INTERNATIONAL GmbH | NEW MODULATORS OF DOPAMINE NEUROTRANSMISSION | Details |
| P 702 | Glaxo Group Limited | Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[{(4-aminophenyl)sulfonyl}(isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamate | Details |
| P 703 | Merck Frosst Canada Ltd | CYCLOPENTANOINDOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | Details |
| P 704 | NOVARTIS AG | BICYCLIC HETEROAROMATIC COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS | Details |
| P 705 | Glaxo Group Limited | A NOVEL POLYMORPHIC CRYSTALLINE FORM OF FLUTICASONE PROPIONATE, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THEREOF | Details |
| P 706 | GlaxoSmithKline S.p.A | QUINOLINE DERIVATIVES AS NK3 ANTAGONISTS | Details |
| P 707 | GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO. 2) | SWALLOW TABLET COMPRISING PARACETAMOL | Details |
| P 708 | Glaxo Group Limited | PROCESS FOR THE SYNTHESIS OF HIV PROTEASE INHIBITORS | Details |
| P 709 | GLAXO GROUP LIMITED | 2,3-DIARYL-PYRAZOLO(1,5-B)PYRIDAZINES DERIVATIVES, THEIR PREPARATION AND THEIR USE AS CYCLOOXYGENASE 2 (COX-2) INHIBITORS | Details |
| P 710 | MSD ITALIA S.R.L. | N-SUBSTITUTED HYDROXYPYRIMIDINONE CARBOXAMIDE INHIBITORS OF HIV INTEGRASE | Details |
| P 711 | ARENA PHARMACEUTICALS, INC. & MERCK & CO., INC. | TETRAZOLE DERIVATIVES AND METHODS OF TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF | Details |
| P 712 | SMITHKLINE BEECHAM PLC | THIAZOLIDINEDIONE DERIVATIVE AND ITS USE AS ANTIDIABETIC | Details |
| P 713 | MERCK SHARP & DOHME LLC | BETA-AMINO TETRAHYDROIMIDAZO (1,2-A)PYRAZINES AND TETRAHYDROTRIAZOLO (4,3-A)PYRAZINES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | Details |
| P 714 | CLEAN CURRENT LIMITED PARTNERSHIP | UNDERWATER DUCTED TURBINE | Details |
| P 715 | LILLY ICOS LLC | COMPOSITION COMPRISING PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION | Details |
| P 716 | ASTRAZENECA AB | NEW FORMULATION FOR INHALATION HAVING A POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, COMPRISING FORMOTEROL | Details |
| P 717 | THERAVANCE, INC | $G(B)2-ADRENERGIC RECEPTOR AGONISTS | Details |
| P 718 | SMITHKLINE BEECHAM CORPORATION | METERED DOSE INHALER FOR SALMETEROL | Details |
| P 719 | GLAXO GROUP LIMITED | ACRIDINE DERIVATIVE FOR INCREASING THE ORAL BIOAVAILABILITY OF TAXOL | Details |
| P 720 | ASTRAZENECA AB | NEW FORMULATION FOR INHALATION HAVING POURED BULK DENSITY OF FROM 0.28 TO 0.38 G/ML, COMPRISING TERBUTALINE SULPHATE, A PROCESS FOR PREPARING THE FORMULATION AND THE USE THEREOF | Details |
| P 721 | ASTRAZENECA AB | NEW FORMULATION FOR INHALATION HAVING POURED BULK DENSITY OF 0.28 TO 0.38 G/ML, A PROCESS FOR PREPARING THE FORMULATION AND THE USE THEREOF | Details |
| P 722 | MELVIN MOLNICK | METHOD OF PARTICIPATING IN A LIVE CASINO GAME FROM A REMOTE LOCATION | Details |
| P 723 | ASTRAZENECA UK LIMITED | NOVEL THIAZOLO (4,5-D) PYRIMIDINE COMPOUNDS | Details |
| P 724 | PFIZER PRODUCTS INC. | PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS | Details |
| P 725 | GENENTECH, INC. | HUMANIZED HEREGULIN ANTIBODY | Details |
| P 726 | PFIZER HEALTH AB | STRUCTURE AND METHOD FOR JOINING PARTS | Details |
| P 727 | PFIZER INC. | INCLUSION COMPLEXES OF ARYL-HETEROCYCLIC SALTS | Details |
| P 728 | PHARMACIA & UPJOHN COMPANY | METHOD FOR THE PREPARATION OF ARYL ETHERS | Details |
| P 729 | SEIKO EPSON CORPORATION | INK CARTRIDGE AND INK-JET RECORDING APPARATUS | Details |
| P 730 | SEIKO EPSON CORPORATION | INK SUPPLY UNIT | Details |
| P 731 | WARNER-LAMBERT COMPANY LLC | METHOD FOR PREVENTING OR DELAYING CATHETER-BASED REVASCULARIZATION | Details |
| P 732 | ASTRAZENECA AB | NOVEL TRIAZOLO(4,5-D)PYRIMIDINE COMPOUNDS | Details |
| P 733 | AGOURON PHARMACEUTICALS, INC. | PROCESS FOR PREPARING OXAZOLINES FROM TETRAHYDROFURANS | Details |
| P 734 | PFIZER INC. AND PFIZER LIMITED | TRIAZOLYL TROPANE DERIVATIVES AS CCR5 MODULATORS | Details |
| P 735 | ASTRAZENECA AB | ADAMANTANE DERIVATIVES | Details |
| P 736 | WARNER-LAMBERT COMPANY | ASYMMETRIC SYNTHESIS OF PREGABALIN | Details |
| P 737 | AGOURON PHARMACEUTICALS, INC. | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASES | Details |
| P 738 | PFIZER PRODUCTS INC. | PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS | Details |
| P 739 | PFIZER PRODUCTS INC. | 4-AMINO SUBSTITUTED-2-SUBSTITUTED-1,2,3,4-TETRAHYDROQUINOLINES AS CETP INHIBITORS | Details |
| P 740 | PFIZER LIMITED | PYRROLO 2,3-D]PYRIMIDINE COMPOUNDS | Details |
| P 741 | CSL LIMITED AND UNIVERSITY OF QUEENSLAND | VACCINE AGAINST HUMAN PAPILLOMAVIRUS (TYPE 18) | Details |
| P 742 | AAC TRADE LTD | COOKING APPLIANCE AND METHOD PARTICULARLY USEFUL FOR DEEP-FRYING FOOD ARTICLES | Details |
| P 743 | GLAXO GROUP LIMITED | PIPERAZINE COMPOUNDS AS TACHYKININS ANTAGONISTS | Details |
| P 744 | ASTRAZENECA AB | QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS | Details |
| P 745 | PFIZER PRODUCTS INC. | ISOTHIAZOLE DERIVATIVES USEFUL AS ANTICANCER AGENTS | Details |
| P 746 | PFIZER PRODUCTS INC. | THERAPEUTIC COMBINATIONS COMPRISING AMLODIPIN AND ATORVASTATIN | Details |
| P 747 | SmithKline Beecham Corporation | NOVEL METHOD OF TREATMENT | Details |
| P 748 | SEIKO EPSON CORPORATION | INKJET RECORDING APPARATUS AND INK CARTRIDGE | Details |
| P 749 | SEIKO EPSON CORPORATION | INK CARTRIDGE AND PRINTER USING THE SAME | Details |
| P 750 | SEIKO EPSON CORPORATION | PRINTER AND INK CARTRIDGE ATTACHED THERETO | Details |
| P 751 | SEIKO EPSON CORPORATION | INK CARTRIDGE ATTACHMENT/DETACHMENT DEVICE, RECORDING APPARATUS, LIQUID EJECTION APPARATUS, AND LIQUID CONTAINER | Details |
| P 752 | SEIKO EPSON CORPORATION | INK CARTRIDGE ATTACHMENT/DETACHMENT DEVICE, RECORDING APPARATUS, LIQUID EJECTION APPARATUS, AND LIQUID CONTAINER | Details |
| P 753 | GLAXOSMITHKLINE BIOLOGICALS S.A. | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | Details |
| P 754 | SMITHKLINE BEECHAM CORPORATION & SMITHKLINE BEECHAM PLC | PLEUROMUTILIN DERIVATIVES AS ANTIMICROBIALS | Details |
| P 755 | GLAXO GROUP LIMITED | CHEMICAL COMPOUNDS | Details |
| P 756 | GLAXO GROUP LIMITED | PROCESS FOR THE PREPARATION OF 3-OXO-4-AZASTEROIDS | Details |
| P 757 | SCHWARZ PHARMA AG | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | Details |
| P 758 | ARENA PHARMACEUTICALS, INC. | 5HT2C RECEPTOR MODULATORS | Details |
| P 759 | MERCK SHARP & DOHME LLC | PHOSPHORIC ACID SALT OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR | Details |
| P 760 | PFIZER LIMITED | PYRAZOLO[4,3-D]PYRIMIDINE DERIVATIVES | Details |
| P 761 | AGOURON PHARMACEUTICALS, INC. | HIV PROTEASE INHIBITORS | Details |
| P 762 | SEIKO EPSON CORPORATION | INK CARTRIDGE FOR INK JET RECORDING APPARATUS | Details |
| P 763 | SEIKO EPSON CORPORATION | INK CARTRIDGE FOR INK JET RECORDING APPARATUS | Details |
| P 764 | SEIKO EPSON CORPORATION | INK CARTRIDGE AND INK CARTRIDGE HOLDER | Details |
| P 765 | SEIKO EPSON CORPORATION | INKJET RECORDING APPARATUS AND INK CARTRIDGE | Details |
| P 766 | SEIKO EPSON CORPORATION | A PRINTING APPARATUS AND INK CARTRIDGE THEREFOR | Details |
| P 767 | SEIKO EPSON CORPORATION | A PRINTING APPARATUS AND INK CARTRIDGE THEREFOR | Details |
| P 768 | Glaxo Group Limited | PYRROLIDINE DERIVATIVES AS FACTOR XA INHIBITORS | Details |
| P 769 | ASTRAZENECA AB | NEW AMINOPROPYLPHOSPHINIC ACIDS | Details |
| P 770 | PFIZER LIMITED | PROCESS FOR PREPARATION OF PYRAZOLO-(4,3-D)PYRIMIDIN-7-ONES AND INTERMEDIATES THEREOF | Details |
| P 771 | PHARMACIA & UPJOHN COMPANY LLC | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HYPERPLASIA AND OTHER DISEASES | Details |
| P 772 | ASTRAZENECA AB | PIPERIDINE DERIVATIVES AS POTASSIUM CHANNEL BLOCKERS | Details |
| P 773 | GLAXO GROUP LIMITED | CRYSTALLINE DERIVATIVES OF 2-(5-CHLOROTHIEN-2-YL)-N-((3S)-1((1S)-1-METHYL-2-MORPHOLIN-4-YL)-2-OXOETHYL)-2-OXOPYRROLIDIN-3-YL)ETHENSULFONAMIDE | Details |
| P 774 | GLAXO GROUP LIMITED | CHEMICAL COMPOUNDS | Details |
| P 775 | SMITHKLINE BEECHAM PLC | PIPERIDINES FOR USE AS OREXIN RECEPTOR ANTAGONISTS | Details |
| P 776 | PHARMACIA & UPJOHN COMPANY LLC | (S,S)-REBOXETINE FOR TREATING PERIPHERAL NEUROPATHY | Details |
| P 777 | PHARMACIA CORPORATION | AMIDINO COMPOUND AND SALTS THEREOF USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS | Details |
| P 778 | SMITHKLINE BEECHAM PLC & SMITHKLINE BEECHAM CORPORATION | MULTILAYER TABLET COMPRISING ROSIGLITAZONE | Details |
| P 779 | PHARMACIA & UPJOHN COMPANY LLC | (S,S)-REBOXETINE FOR TREATING FIBROMYALGIA AND OTHER SOMATOFORM DISORDERS | Details |
| P 780 | PHARMACIA CORPORATION | (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(N+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY | Details |
| P 781 | KUDOS PHARMACEUTICALS LIMITED | PHTHALAZINONE DERIVATIVES | Details |
| P 782 | THERAVANCE, INC. | BETA 2-ADRENERGIC RECEPTOR AGONISTS | Details |
| P 783 | NOVARTIS AG | THROMBOPOIETIN MIMETICS | Details |
| P 784 | MERCK SHARP & DOHME LIMITED and SCHERING CORPORATION | COMPOSITION DEVOID OF ASCORBIC ACID COMPRISING A CHOLESTEROL ABSORPTION INHIBITOR, AN HMG-COA REDUCTASE INHIBITOR AND A STABILIZING AGENT | Details |
| P 785 | MERCK CANADA LTD and AXYS PHARMACEUTICALS, INC. | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | Details |
| P 786 | GLAXO GROUP LIMITED | OXIDATION PROCESS FOR PREPARING THE INTERMEDIATE 6.ALPHA.,9.ALPHA.-DIFLUORO-11.BETA.,17.ALPHA.-DIHYDROXY-16.ALPHA.-METHYL-ANDROST-1,4-DIEN-3-ONE 17.BETA.-CARBOXYLIC ACID | Details |
| P 787 | ASTRA ZENECA AB | COMPOUNDS AFFECTING GLUCOKINASE | Details |
| P 788 | GLAXO GROUP LIMITED | THERAPEUTIC BIARYLO DERIVATIVES | Details |
| P 789 | ARENA PHARMACEUTICALS, INC. | DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | Details |
| P 790 | AXOVANT SCIENCES GmbH | QUINOLINE DERIVATIVES AND THEIR USE AS 5-HT6 LIGANDS | Details |
| P 791 | COLEY PHARMACEUTICAL GmbH and UNIVERSITY OF IOWA RESEARCH FOUNDATION | IMMUNOSTIMULATORY NUCLEIC ACIDS | Details |
| P 792 | PHARMACIA & UPJOHN COMPANY LLC | (S,S)-REBOXETINE FOR TREATING MIGRAINE HEADACHES | Details |
| P 793 | PHARMACIA & UPJOHN COMPANY LLC | REBOXETINE FOR TREATING PERIPHERAL NEUROPATHY | Details |
| P 794 | PHARMACIA & UPJOHN COMPANY LLC | REBOXETINE FOR TREATING MIGRAINE HEADACHES | Details |
| P 795 | Pharmacia & Upjohn Company LLC | (S,S)-reboxetine for trating incontinence | Details |
| P 796 | GENZYME CORPORATION | QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS | Details |
| P 797 | JAGOTEC AG | ROPINIROLE-CONTAINING HYDROPHILIC/LIPHILIC POLYMERIC MATRIX DOSAGE FORMULATION | Details |
| P 798 | SKYSAILS GMBH & CO., KG | WIND-PROPELLED WATERCRAFT | Details |
| P 799 | MERCK SHARP & DOHME CORP. | TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 | Details |
| P 800 | GILAED SCIENCES, INC | VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) NUCLEIC ACID LIGAND COMPLEXES | Details |
| P 801 | ASTRAZENECA AB | NEW FORMULATION | Details |
| P 802 | ARENA PHARMACEUTICALS, INC. | SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO | Details |
| P 803 | PHARMACIA & UPJOHN COMPANY LLC | (S,S)-REBOXETINE FOR TREATING CHRONIC PAIN | Details |
| P 804 | WARNER-LAMBERT COMPANY LLC | INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE | Details |
| P 805 | WARNER-LAMBERT COMPANY LLC | CYCLIC AMINO ACIDS AND DERIVATIVES THEREOF USEFUL AS PHARMACEUTICAL AGENTS | Details |
| P 806 | BRISTOL-MYERS SQUIBB COMPANY | C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND METHOD | Details |
| P 807 | NOVARTIS AG | HIGH DRUG LOAD TABLET | Details |
| P 808 | NOVARTIS AG | INHIBITORS OF TYROSINE KINASES | Details |
| P 809 | PFIZER PRODUCTS INC. | THERAPEUTIC COMBINATIONS COMPRISING AMLODIPINE AND ATORVASTATIN | Details |
| P 810 | SMITHKLINE BEECHAM PLC | PYRIMIDINE-4-ONE DERIVATIVE AS LDL-PLA2 INHIBITOR | Details |
| P 811 | ASTRAZENECA AB | REFLUX INHIBITORS | Details |
| P 812 | OTTAWA HOSPITAL RESEARCH INSTITUTE | METHODS AND PRODUCTS FOR INDUCING MUCOSAL IMMUNITY | Details |
| P 813 | GLAXO GROUP LIMITED | USE OF AN ANTAGONIST ANTIBODY TO THE INFLAMMATORY MEDIATOR ONCOSTATIN M (OSM) | Details |
| P 814 | PFIZER ITALIA S.r.l. | PHENYLACETAMIDO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS | Details |
| P 815 | GLAXOSMITHKLINE BIOLOGICALS NIEDERLASSUNG DER SMITHKLINE BEECHAM PHARMA | INFLUENZA VACCINE COMPOSITION | Details |
| P 816 | MERCK SHARP & DOHME CORP. | METHOD OF TREATING ATHEROSCLEROSIS, DYSLIPIDEMIAS AND RELATED CONDITIONS AND PHARMACEUTICAL COMPOSITIONS | Details |
| P 817 | TARGACEPT, INC. | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | Details |
| P 818 | BRISTOL-MYERS SQUIBB HOLDINGS IRELAND UNLIMITED COMPANY | LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS | Details |
| P 819 | PFIZER LIMITED | PYRAZOLE DERIVATIVES FOR TREATING HIV | Details |
| P 820 | LASSER FAMILY PARTNERSHIP, L.P. | CONCENTRATED X-RAY CONTRAST MEDIA CAN ACT AS UNIVERSAL ANTIGENS AND CAN INHIBIT OR PREVENT ALLERGIC REACTIONS | Details |
| P 821 | GLAXOSMITHKLINE BIOLOGICALS S.A. | ADJUVANT SYSTEMS AND VACCINES | Details |
| P 822 | TARGACEPT, INC. | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF | Details |
| P 823 | TARGACEPT, INC. | ARYLVINYLAZACYCLOALKANE COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF | Details |
| P 824 | TARGACEPT, INC. | PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS COMPRISING A NICOTINE ANALOG AND AN ACETYLCHOLINESTERASE INHIBITOR | Details |
| P 825 | TARGACEPT INC. | N-ARYL DIAZASPIRACYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF | Details |
| P 826 | Targacept Inc | Azabicyclic compounds for relieving PAIN and treating central nervous system disorders | Details |
| P 827 | ROTECH HOLDINGS LIMITED | POWER GENERATOR AND TURBINE UNIT | Details |
| P 828 | ROTECH HOLDINGS LIMITED | UNDERWATER POWER GENERATOR | Details |
| P 829 | PFIZER LIMITED | SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES | Details |
| P 830 | PHARMACIA & UPJOHN COMPANY LLC & SUGEN, INC. | PYRROLE SUBSTITUTED 2-INDOLINONE PROTEIN KINASE INHIBITORS | Details |
| P 831 | AGOURON PHARMACEUTICALS, LLC | INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEIN KINASES, AND METHODS FOR THEIR USE | Details |
| P 832 | PFIZER LIMITED | IMIDAZOPYRIDINE SUBSTITUTED TROPANE DERIVATIVES WITH CCR5 RECEPTOR ANTAGONIST ACTIVITY FOR THE TREATMENT OF HIV AND INFLAMMATION | Details |
| P 833 | PFIZER LIMITED | COMPOSITIONS CONTAINING PYRROLO Ź2,3-d PYRIMIDINE DERIVATIVES | Details |
| P 834 | PFIZER LIMITED | SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES | Details |
| P 835 | SCHERING CORPORATION | TRICYCLIC THROMBIN RECEPTOR ANTAGONISTS | Details |
| P 836 | GLAXO GROUP LIMITED | ANTIBODIES AGAINST AMYLOID-BETA PEPTIDE | Details |
| P 837 | MERCK SHARP & DOHME CORP. | HCV NS3 PROTEASE INHIBITORS | Details |
| P 838 | MERCK SHARP & DOHME CORP. | MEDICAL USE OF A TETRAHYDROTRIAZOLO[4,3-a]PYRAZINE | Details |
| P 839 | GLAXOSMITHKLINE BIOLOGICALS S.A. | VACCINES AGAINST CANCERS | Details |
| P 840 | MERCK SHARP & DOHME CORP. | PHARMACEUTICAL COMPOSITION CONTAINING PROTON PUMP INHIBITORS | Details |
| P 841 | ASTRAZENECA AB | USE OF ROSUVASTATIN (ZD-4522) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | Details |
| P 842 | PFIZER PRODUCTS INC. | ARYL FUSED AZAPOLYCYCLIC COMPOUNDS | Details |
| P 843 | NOVARTIS AG | SOMATOSTATIN ANALOGUES | Details |
| P 844 | FREDA RUDERHAM | A STORAGE CHEST | Details |
| P 845 | GLAXO GROUP LIMITED | PHENETHANOLAMINE DERIVATIVES FOR TREATMENT OF RESPIRATORY DISEASES | Details |
| P 846 | GLAXO GROUP LIMITED | 6.ALPHA.,9.ALPHA.-DIFLUORO-17.ALPHA.-(2-FURANYLCARBOXYL)OXY-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT | Details |
| P 847 | GLAXOSMITHKLINE BIOLOGICALS S.A. | VACCINE AGAINST ANTIGENS FROM BACTERIAE | Details |
| P 848 | GLAXO GROUP LIMITED | QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING AFFINITY FOR 5HT1-TYPE RECEPTORS | Details |
| P 849 | UNIVERSITY OF SOUTH FLORIDA | EXO-S-MECAMYLAMINE FORMULATION | Details |
| P 850 | UCB PHARMA GmbH | USE OF R-(+)-2(3-DIISOPROPYLAMINO-1-PHENYLPROPYL)-4-HYDROXY-METHYL-PHENYL ISOBUTYRIC ACID ESTER HYDROGENFUMARATE FOR THE TREATMENT OF URINARY INCONTINENCE AND OTHER SPASMOGENIC DISORDERS | Details |
| P 851 | Merck Sharp & Dohme Corp. | TRICYCLIC THROMBIN RECEPTOR ANTAGONISTS | Details |
| P 852 | Merck Sharp & Dohme Corp. | TRICYCLIC THROMBIN RECEPTOR ANTAGONIST | Details |
| P 853 | PFIZER PRODUCTS INC. | IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | Details |
| P 854 | TARGACEPT, INC. | ARYLVINYLAZACYCLOALKANE COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF | Details |
| P 855 | INTERMUNE, INC. | REDUCTION OF DIZZINESS, A SIDE EFFECT ASSOCIATED WITH PIRFENIDONE THERAPY | Details |
| P 856 | TARGACEPT, INC. | NICOTINIC ACETYLCHOLINE RECEPTORSUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES | Details |
| P 857 | PFIZER LIMITED | TRIAZOLYL TROPANE DERIVATIVES AS CCR5 MODULATORS | Details |
| P 858 | ASTRAZENECA AB | PYRAZOLE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES | Details |
| P 859 | ASTRAZENECA AB | 1,2,3,4-TETRASUBSTITUTED INDOLE FOR THE TREATMENT OF RESPIRATORY DISEASES | Details |
| P 860 | Abloy Oy | DISC TUMBLER CYLINDER LOCK AND KEY COMBINATION | Details |
| P 861 | Pfizer Limited | TRIAZOLOPYRIDINYLSULFANYL DERIVATIVES AS P38 MAP KINASE INHIBITORS | Details |
| P 862 | MERCK SHARP & DOHME CORP. | USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASES | Details |
| P 863 | MERCK SHARP & DOHME CORP. | USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASES | Details |
| P 864 | TARGACEPT, INC. | N-ARYL DIAZASPIRACYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF | Details |
| P 865 | PFIZER LIMITED | CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | Details |
| P 866 | MERCK SHARP & DOHME CORP. | POLYCYCLIC INDAZOLE DERIVATIVES THAT ARE ERK INHIBITORS | Details |
| P 867 | SMITHKLINE BEECHAM CORPORATION | 3'-(2Z)-1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE HYDRAZINO-2'-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID BIS-(MONOETHANOLAMINE) | Details |
| P 868 | BIOGEN IDEC MA INC. AND TOPOTARGET SWITZERLAND SA | AN ANTIBODY SPECIFIC FOR SOLUBLE BAFF FOR USE IN THE TREATMENT OF CANCER | Details |
| P 869 | ROTECH HOLDINGS LIMITED | POWER GENERATING APPARATUS WITH WATER TURBINE WITH BI-SYMMETRIC AIRFOIL | Details |
| P 870 | Pfizer Limited and Pfizer Inc. | 5,7-DIAMINOPYRAZOLO-4,3-D PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION | Details |
| P 871 | PFIZER PRODUCTS INC. | PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)DERIVATIVE USED AS PDE5 INHIBITORS | Details |
| P 872 | PFIZER PRODUCTS INC. | METHOD FOR ENZYMATIC PREPARATION OF (S)-3-CYANO-5-METHYLHEXANOIC ACID | Details |
| P 873 | UCB PHARMA GmbH | STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES | Details |
| P 874 | ASTRAZENECA AB | 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS | Details |
| P 875 | MERCK SHARP & DOHME CORP. | HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS | Details |
| P 876 | PHARMACIA CORPORATION | SUBSTITUTED PYRIDINONES AS MODULATORS OF P38 MAP KINASE | Details |
| P 877 | WARNER-LAMBERT COMPANY LLC | PREPARATION OF PREGABALIN AND RELATED COMPOUNDS | Details |
| P 878 | ASTRAZENECA AB | QUINICLIDINE DERIVATIVES OF (HETERO) ARYLCYCLOHEPTANECARBOXYLIC ACID AS MUSCARINIC RECEPTOR ANTAGONISTS | Details |
| P 879 | RIGEL PHARMACEUTICALS, INC. | PRODRUGS OF 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES | Details |
| P 880 | ASTRAZENECA AB | PYRIDINE CARBOXAMIDES AS 11-BETA-HSD1 INHIBITORS | Details |
| P 881 | ARRAY BIOPHARMA, INC. & ASTRAZENECA AB | N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS | Details |
| P 882 | PFIZER INC. | ENANTIOMERICALLY PURE AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS | Details |
| P 883 | ARRAY BIOPHARMA, INC. | QUINAZOLINE ANALOGS AS RECEPTOR TYROSINE KINASE INHIBITORS | Details |
| P 884 | PFIZER PRODUCTS INC. | HETEROAROMATIC QUINOLINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS | Details |
| P 885 | PULMAGEN THERAPEUTICS (SYNERGY) LIMITED | AZOLE AND THIAZOLE DERIVATIVES AND THEIR USE | Details |
| P 886 | ARIAD PHARMACEUTICALS, INC. | BICYCLIC HETEROARYL COMPOUNDS | Details |
| P 887 | PFIZER IRELAND PHARMACEUTICALS | COMPOSES HETEROCYCLIQUES, ACTIFS COMME INHIBITEURS DE BETA-LACTAMASES | Details |
| P 888 | ROTECH HOLDINGS LIMITED | UNDERWATER POWER GENERATOR | Details |
| P 889 | SABIC INNOVATIVE PLASTICS IP B.V. | MULTILAYERED ARTICLES AND METHOD OF MANUFACTURE THEREOF | Details |
| P 890 | MERCK SHARP & DOHME CORP. | ARYL METHYL BENZOQUINAZOLINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | Details |
| P 891 | MERCK SHARP & DOHME LLC & MSD ITALIA S.R.L. | MACROCYCLIC QUINOXALINE COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS | Details |
| P 892 | PFIZER ITALIA S.r.l. | BICYCLO-PYRAZOLES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | Details |
| P 893 | PFIZER LIMITED | 5,7-DIAMINOPYRAZOLO[4,3-D]PYRIMIDINES WITH PDE-5 INHIBITING ACTIVITY | Details |
| P 894 | TARGACEPT, INC. | (2S,3R)-N-(2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3-YL)BENZOFURAN-2-CARBOXAMIDE, NOVEL SALT FORMS, AND METHODS OF USE THEREOF | Details |
| P 895 | MERCK SHARP & DOHME CORP. | USE OF MAMMALIAN CYTOKINE-RELATED REAGENTS | Details |
| P 896 | PANMIRA PHARMACEUTICALS, LLC | 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS | Details |
| P 897 | GLAXO GROUP LIMITED | TRICYCLIC NITROGEN CONTAINING COMPOUNDS AS ANTIBACTERIAL AGENTS | Details |
| P 898 | PFIZER HEALTH AB | THERAPEUTIC FORMULATION FOR ADMINISTERING TOLTERODINE WITH CONTROLLED RELEASE | Details |
| P 899 | PFIZER PRODUCTS INC. | TRICYCLIC COMPOUNDS AND THEIR USE AS GLUCOCORTICOID RECEPTOR MODULATORS | Details |
| P 900 | SEAGEN INC. | AURISTATIN CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE | Details |
| P 901 | ASTRAZENECA AB & ARRAY BIOPHARMA, INC. | PHARMACEUTICAL COMPOSITION 271 | Details |
| P 902 | PFIZER INC. | PYRAZOLE-SUBSTITUTED AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS | Details |
| P 903 | PFIZER INC. | 3-AMINOCYCLOPENTANECARBOXAMIDES AS CHEMOKINE RECEPTOR MODULATORS | Details |
| P 904 | !OBAC LIMITED | A METHOD OF LAYING A FLOOR COVERING | Details |
| P 905 | ASTRAZENECA AB | ACYLAMINOPYRAZOLES AS FGFR INHIBITORS | Details |
| P 906 | MERCK SHARP & DOHME CORP. | AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES | Details |
| P 907 | ECOSCREED (C.I.) LTD | SCREED COMPRISING RECYCLED GLASS WASTE | Details |
| P 908 | ASTRAZENECA AB | NEW CRYSTALLINE AND AMORPHOUS FORM OF A TRIAZOLO(4,5-D)PYRIMIDINE COMPOUND | Details |
| P 909 | UCB PHARMA GmbH | STABILIZED PHARMACEUTICAL COMPOSITIONS COMPRISING FESOTERODINE | Details |
| P 910 | PFIZER PRODUCTS INC. | TRICYCLIC COMPOUNDS AND THEIR USE AS GLUCOCORTICOID RECEPTOR MODULATORS | Details |
| P 911 | GLAXOSMITHKLINE BIOLOGICALS S.A. | LIVE ATTENUATED ROTAVIRUS VACCINE FOR ORAL ADMINISTRATION | Details |
| P 912 | MERCK SHARP & DOHME CORP. | 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS | Details |
| P 913 | MERCK SHARP & DOHME CORP. | ANACETRAPIB AND OTHER CETP INHIBITORS | Details |
| P 914 | KUDOS PHARMACEUTICALS LTD | PYRIDO-, PYRAZO- AND PYRIMIDOPYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | Details |
| P 915 | MERCK SHARP & DOHME B.V. | N-(1,1,1,3,3,3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) BENZYL-N'-ARYLCARBONYLPIPERAZINE DERIVATIVES AS LXR MODULATORS | Details |
| P 916 | ASTRAZENECA AB & PULMAGEN THERAPEUTICS (SYNERGY) LIMITED | COMPOUNDS | Details |
| P 917 | WARNER-LAMBERT COMPANY LLC | 4-PHENYLAMINO-QUINAZOLIN-6-YL-AMIDES | Details |
| P 918 | INCYTE HOLDINGS CORPORATION | Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus Kinase inhibitors | Details |
| P 919 | ASTRAZENECA AB | PYRIMIDINE SULPHONAMIDE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS | Details |
| P 920 | PFIZER INC. | DIOXA-BICYCLO[3.2.1.]OCTANE-2,3,4-TRIOL DERIVATIVES | Details |
| P 921 | PFIZER INC. | AMINO-HETEROCYCLIC COMPOUNDS | Details |
| P 922 | MERCK SHARP & DOHME CORP., & 2 others (please see file for names) | OXYNTOMODULIN ANALOGS | Details |
| P 923 | MERCK SHARP & DOHME B.V. | ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 | Details |
| P 924 | ASTRAZENECA AB | INHALATION DEVICE FOR DRUGS IN POWDER FORM | Details |
| P 925 | NEKTAR THERAPEUTICS | MONODISPERSE PEGYLATED NALOXOL COMPOSITIONS | Details |
| P 926 | JANSSEN SCIENCES IRELAND UC & WYETH LLC | HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE | Details |
| P 927 | WYETH LLC | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | Details |
| P 928 | PFIZER IRELAND PHARMACEUTICALS | HETEROCYCLIC COMPOUNDS THAT ARE ACTIVE AS BETA LACTAMASE INHIBITORS | Details |
| P 929 | 3M INNOVATIVE PROPERTIES COMPANY | 1-ALKOXY 1H-IMIDAZO RING SYSTEMS AND METHODS | Details |
| P 930 | MERCK SHARP & DOHME CORP. & MERCK CANADA INC. | COMPOSITION FOR INHIBITION OF CATHEPSIN K | Details |
| P 931 | ARRAY BIOPHARMA, INC. & ASTRAZENECA AB | NOVEL HYDROGEN SULFATE SALT | Details |
| P 932 | ASTRAZENECA AB | PYRROLO[2,3-D]PYRIMIDIN DERIVATIVES AS PROTEIN KINASE B INHIBITORS | Details |
| P 933 | MERCK SHARP & DOHME LLC | BETA-LACTAMASE INHIBITORS | Details |
| P 934 | ASTRAZENECA AB | MORPHOLINO PYRIMIDINES AND THEIR USE IN THERAPY | Details |
| P 935 | ASTRAZENECA AB | SUBSTITUTED CINNOLINE DERIVATIVES AS GABAA-RECEPTOR MODULATORS AND METHOD FOR THEIR SYNTHESIS | Details |
| P 936 | ASTRAZENECA AB | NOVEL PYRROLO [3, 2-d]PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE IN THERAPY | Details |
| P 937 | GILEAD SCIENCES, INC. | PRODRUGS OF PHOSPHONATE NUCLEOTIDE ANALOGUES AND METHODS FOR SELECTING AND MAKING SAME | Details |
| P 938 | GILEAD SCIENCES, INC. | MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS | Details |
| P 939 | MERCK SHARP & DOHME LLC | SUBSTITUTED DIAZEPAN COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | Details |
| P 940 | ASTRAZENECA AB | PYRAZINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF LUNG DISEASES | Details |
| P 941 | MERCK SHARP & DOHME LLC | PHOSPHORIC ACID SALT OF A DIPEPTIDYL PEPTIDASE-IV INHIBITOR | Details |
| P 942 | ASTRAZENECA AB | OXADIAZOLE DERIVATIVES AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR POTENTIATORS - 842 | Details |
| P 943 | PFIZER PRODUCTS INC. | ARYL FUSED AZAPOLYCYCLIC COMPOUNDS | Details |
| P 944 | GLAXOSMITHKLINE BIOLOGICALS S.A. | VACCINE COMPRISING AN OIL IN WATER EMULSION ADJUVANT | Details |
| P 945 | ASTRAZENECA AB | CHROMENONE DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | Details |
| P 946 | HELIX BIOMEDIX INC. | PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS | Details |
| P 947 | MERCK SHARP & DOHME B.V. | INTRAUTERINE DEPOSIT | Details |
| P 948 | MERCK CANADA INC. | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | Details |
| P 949 | ASTRAZENECA AB | DIBENZOTHIAZEPINE DERIVATIVE AND USE THEREOF | Details |
| P 950 | ALMIRALL, S.A. | COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS | Details |
| P 951 | SEAGEN INC. | DRUG CONJUGATES AND THEIR USE FOR TREATING CANCER, AN AUTOIMMUNE DISEASE OR AN INFECTIOUS DISEASE | Details |
| P 952 | OMYA INTERNATIONAL AG | MICRONIZED CaCO3 SLURRY INJECTION SYSTEM FOR THE REMINERALIZATION OF DESALINATED AND FRESH WATER | Details |
| P 953 | HELIX BIOMEDIX INC. | PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS | Details |
| P 954 | ALMIRALL, S.A. | INHALATION COMPOSITION CONTAINING ACLIDINIUM FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Details |
| P 955 | WYETH LLC | TIGECYCLINE COMPOSITIONS AND METHODS OF PREPARATION | Details |
| P 956 | ELI LILLY AND COMPANY | ECHINOCANDIN PHARMACEUTICAL FORMULATIONS CONTAINING MICELLE-FORMING SURFACTANTS | Details |
| P 957 | CYDEX PHARMACEUTICALS, INC. | SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS AND METHODS OF PREPARATION THEREOF | Details |
| P 958 | GILEAD SCIENCES, INC. | POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE | Details |
| P 959 | HUTCHISON MEDIPHARMA LIMITED | CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR | Details |
| P 960 | MERCK SHARP & DOHME LLC | INHIBITORS OF HEPATITIS C VIRUS REPLICATION | Details |
| P 961 | MERCK SHARP & DOHME LLC | IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | Details |
| P 962 | ASTRAZENECA AB | 2-(2,4,5-SUBSTITUTED-ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER | Details |
| P 963 | ViiV HEALTHCARE COMPANY & SHIONOGI & CO., LTD. | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY | Details |
| P 964 | QUALCOMM INCORPORATED | CODE DIVISION MULTIPLEXING IN A SINGLE-CARRIER FREQUENCY DIVISION MULTIPLE ACCESS SYSTEM | Details |
| P 965 | QUALCOMM INCORPORATED | TRANSMIT SPATIAL DIVERSITY FOR CELLULAR SINGLE FREQUENCY NETWORKS | Details |
| P 966 | QUALCOMM INCORPORATED | LOW OUTPUT SKEW DOUBLE DATA RATE SERIAL ENCODER | Details |
| P 967 | QUALCOMM INCORPORATED | WORD LINE VOLTAGE CONTROL IN STT-MRAM | Details |
| P 968 | QUALCOMM INCORPORATED | ON-CHIP LOW VOLTAGE CAPACITOR-LESS LOW DROPOUT REGULATOR WITH Q-CONTROL | Details |
| P 969 | QUALCOMM INCORPORATED | SYSTEM AND METHOD TO READ AND WRITE DATA AT A MAGNETIC TUNNEL JUNCTION ELEMENT | Details |
| P 970 | QUALCOMM INCORPORATED | MAGNETIC TUNNEL JUNCTION (MTJ) AND METHOD FOR FORMING THE SAME | Details |
| P 971 | QUALCOMM INCORPORATED | FEEDBACK OF CONTROL INFORMATION FOR MULTIPLE CARRIERS | Details |
| P 972 | QUALCOMM INCORPORATED | CQI ESTIMATION IN A WIRELESS COMMUNICATION NETWORK | Details |
| P 973 | QUALCOMM INCORPORATED | ADAPTIVE RESOURCE NEGOTIATION BETWEEN BASE STATIONS FOR ENHANCED INTERFERENCE COORDINATION | Details |
| P 974 | QUALCOMM INCORPORATED | SEMI-PERSISTENT SCHEDULING GRANTS IN HETEROGENEOUS NETWORKS | Details |
| P 975 | QUALCOMM INCORPORATED | MAGNETIC RANDOM ACCESS MEMORY (MRAM) LAYOUT WITH UNIFORM PATTERN | Details |
| P 976 | INCYTE CORPORATION | 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS | Details |
| P 977 | PFIZER PRODUCTS INC. | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ONCE DAILY DOSING CONTAINING PREGABALIN, A MATRIX FORMING AGENT AND A SWELLING AGENT | Details |
| P 978 | PHARMACIA & UPJOHN COMPANY LLC | CRYSTALS INCLUDING A MALIC ACID SALT OF N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOLE-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE, PROCESSES FOR ITS PREPARATION AND COMPOSITIONS THEREOF | Details |
| P 979 | WYETH LLC | CRYSTALLINE FORMS OF 4-[(2,4-DICHLORO-5-METHOXYPHENYL)AMINO]-6-METHOXY-7-[3-(4-METHYL-1-PIPERAZINYL)PROPOXY]-3-QUINOLINECARBONITRILE AND METHODS OF PREPARING THE SAME | Details |
| P 980 | GILEAD PHARMASSET LLC | NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS | Details |
| P 981 | GILEAD SCIENCES, INC. | MODULATORS OF TOLL-LIKE RECEPTORS | Details |
| P 982 | ViiV HEALTHCARE COMPANY & SHIONOGI & CO., LTD. | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVES HAVING HIV INTEGRASE INHIBITORY ACTIVITY | Details |
| P 983 | ABLOY OY | DISC TUMBLER CYLINDER LOCK | Details |
| P 984 | WYETH HOLDINGS LLC | SUBSTITUTED 3-CYANOQUINOLINES AS PROTEIN TYROSINE KINASES INHIBITORS | Details |
| P 985 | MSD K.K. | BICYCLOANILINE DERIVATIVE | Details |
| P 986 | VERTEX PHARMACEUTICALS INCORPORATED | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | Details |
| P 987 | MERCK SHARP & DOHME CORP. | FUSED BICYCLIC OXAZOLIDINONE CETP INHIBITOR | Details |
| P 988 | ASTRAZENECA AB & BAYER PHARMA AKTIENGESELLSCHAFT | BENZODIOXINYL SUBSTITUTED INDAZOLE DERIVATIVES | Details |
| P 989 | MARKS & SPENCER PLC | A METHOD FOR FITTING A BRA | Details |
| P 990 | WARNER-LAMBERT COMPANY LLC | OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS | Details |
| P 991 | MSD K.K. | DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE | Details |
| P 992 | VERTEX PHARMACEUTICALS INCORPORATED | HETEROCYCLIC MODULATORS OF ATP - BINDING CASSETTE TRANSPORTERS | Details |
| P 993 | SUGEN, INC. | AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS | Details |
| P 994 | MERIDIAN MEDICAL TECHNOLOGIES, INC. | AUTOMATIC INJECTOR | Details |
| P 995 | GILEAD PHARMASSET LLC | ANTIVIRAL COMPOUNDS | Details |
| P 996 | GILEAD SCIENCES, INC. | INHIBITORS OF HEPATITIS C VIRUS | Details |
| P 997 | GILEAD SCIENCES, INC. | APOPTOSIS SIGNAL-REGULATING KINASE INHIBITOR | Details |
| P 998 | GILEAD PHARMASSET LLC | CONDENSED IMIDAZOLYLIMIDAZOLES AS ANTIVIRAL COMPOUNDS | Details |
| P 999 | ASTRAZENECA AB | COMPOUNDS AND THEIR USE AS BACE INHIBITORS | Details |
| P 1000 | HEPTARES THERAPEUTICS LIMITED | 1,2,4-TRIAZINE-4-AMINE DERIVATIVES | Details |
| P 1001 | PFIZER PRODUCTS INC. | BICYCLIC [3.1.0] HETEROARYL AMIDES AS TYPE I GLYCINE TRANSPORT INHIBITORS | Details |
| P 1002 | BIOGEN MA INC. | HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF | Details |
| P 1003 | KUDOS PHARMACEUTICALS LIMITED | PHARMACEUTICAL FORMULATION 514 | Details |
| P 1004 | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | GLUCAGON/GLP-1 RECEPTOR CO-AGONISTS | Details |
| P 1005 | KUDOS PHARMACEUTICALS LIMITED | 2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS | Details |
| P 1006 | VERTEX PHARMACEUTICALS INCORPORATED | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | Details |
| P 1007 | 3M INNOVATIVE PROPERTIES COMPANY | LIPIDATED IMMUNE RESPONSE MODIFIER COMPOUND COMPOSITIONS, FORMULATIONS, AND METHODS | Details |
| P 1008 | HELIX BIOMEDIX INC. | TETRAPEPTIDES DERIVED FROM HUMAN C-X-C CHEMOKINES USEFUL FOR TREATMENT OF VARIOUS SKIN CONDITIONS | Details |
| P 1009 | ABLOY OY | KEY AND DISC TUMBLER CYLINDER LOCK | Details |
| P 1010 | UNIVERSITY OF ZURICH | ANTI-BETA-AMYLOID ANTIBODY AND USES THEREOF | Details |
| P 1011 | ASTRAZENECA AB | COMPOSITIONS, SUITABLE FOR ORAL ADMINISTRATION, COMPRISING A TRIAZOLO [4,5-D]PYRIMIDIN DERIVATE | Details |
| P 1012 | WYETH LLC | PROCESSES FOR THE CONVERGENT SYNTHESIS OF CALICHEAMICIN DERIVATIVES | Details |
| P 1013 | HOSPIRA, INC. | INJECTION DEVICE AND METHOD OF ASSEMBLY AND ACTIVATION | Details |
| P 1014 | HELIX BIOMEDIX, INC. | SHORT BIO-ACTIVE PEPTIDES FOR PROMOTING WOUND HEALING | Details |
| P 1015 | ASTRAZENECA AB | THERAPEUTIC POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME | Details |
| P 1016 | MEDIMMUNE LIMITED | TARGETED BINDING AGENTS AGAINST B7-H1 | Details |
| P 1017 | NUCANA PLC | FORMULATION COMPRISING A GEMCITABINE-PRODRUG | Details |
| P 1018 | NUCANA PLC | CHEMICAL COMPOUNDS | Details |
| P 1019 | MERCK SHARP & DOHME LLC | A CONDITIONAL REPLICATING CYTOMEGALOVIRUS AS A VACCINE FOR CMV | Details |
| P 1020 | ANACOR PHARMACEUTICALS, INC. | BIOCIDAL BORONOPHTHALIDE COMPOUNDS | Details |
| P 1021 | WYETH LLC | METHODS FOR ENHANCED PRODUCTION OF BONE MORPHOGENETIC PROTEINS | Details |
| P 1022 | WYETH HOLDINGS LLC | CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES | Details |
| P 1023 | ASTRAZENECA AB | 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER | Details |
| P 1024 | GALAPAGOS N.V. | 5-PHENYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-YL CARBOXAMIDES AS JAK INHIBITORS | Details |
| P 1025 | HSBC TECHNOLOGY & SERVICES (USA) INC. | METHOD AND SYSTEM FOR SINGLE SIGN ON WITH DYNAMIC AUTHENTICATION LEVELS | Details |
| P 1026 | RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN | NOVEL RIG-I LIGANDS AND METHODS FOR PRODUCING THEM | Details |
| P 1027 | HELIX BIOMEDIX, INC. | PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS | Details |
| P 1028 | ASTRAZENECA AB | N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS | Details |
| P 1029 | OMTHERA PHARMACEUTICALS INC. & CHRYSALIS PHARMA AG | DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM | Details |
| P 1030 | MERCK SHARP & DOHME LLC | HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS SUITABLE FOR TREATMENT OR PREVENTION OF CENTRAL NERVOUS SYSTEM DISORDERS | Details |
| P 1031 | NCHAIN HOLDINGS LIMITED | DETERMINING A COMMON SECRET FOR THE SECURE EXCHANGE OF INFORMATION AND HIERARCHICAL, DETERMINISTIC CRYPTOGRAPHIC KEYS | Details |
| P 1032 | INCYTE HOLDINGS CORPORATION | HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b] PYRIMIDINES AS JANUS KINASE INHIBITORS | Details |
| P 1033 | MERCK SHARP & DOHME LLC | STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENTS | Details |
| P 1034 | ViiV HEALTHCARE UK (NO 4) LIMITED | COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPRAZINE DERIVATIVES | Details |
| P 1035 | GILEAD SCIENCES, INC. | NOVEL FXR (NR1H4) MODULATING COMPOUNDS | Details |
| P 1036 | INCYTE HOLDINGS CORPORATION | PROCESSES AND INTERMEDIATES FOR MAKING A JAK INHIBITOR | Details |
| P 1037 | INCYTE HOLDINGS CORPORATION | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | Details |
| P 1038 | ViiV HEALTHCARE COMPANY | ANTIVIRAL THERAPY | Details |
| P 1039 | ViiV HEALTHCARE COMPANY | ANTIVIRAL THERAPY | Details |
| P 1040 | INCYTE HOLDINGS CORPORATION | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | Details |
| P 1041 | ASTRAZENECA AB & CANCER RESEARCH TECHNOLOGY LIMITED | 1,3,4-THIADIAZOLE COMPOUNDS AND THEIR USE IN TREATING CANCER | Details |
| P 1042 | CUBIST PHARMACEUTICALS LLC | LIPOPEPTIDE COMPOSITIONS AND RELATED METHODS | Details |
| P 1043 | ASTRAZENECA AB | IMIDAZO[4,5-C]QUINOLIN-2-ONE COMPOUNDS AND THEIR USE IN TREATING CANCER | Details |
| P 1044 | MEDIMMUNE LIMITED | GLUCAGON/GLP-1 AGONISTS FOR THE TREATMENT OF OBESITY | Details |
| P 1045 | ASTRAZENECA AB | BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS | Details |
| P 1046 | INCYTE HOLDINGS CORPORATION | TOPICAL FORMULATION FOR A JAK INHIBITOR | Details |
| P 1047 | MEDIMMUNE LIMITED | COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA | Details |
| P 1048 | HELIX BIOMEDIX INC. | SHORT ANTIMICROBIAL LIPOPEPTIDES | Details |
| P 1049 | HOTPOD HOLDINGS LTD | HEATED INFLATABLE EXERCISE CHAMBER WITH GAS-PERMEABLE INNER MEMBRANE | Details |
| P 1050 | PEARL THERAPEUTICS, INC. | RESPIRATORY DELIVERY OF ACTIVE AGENTS | Details |
| P 1051 | PEARL THERAPEUTICS, INC. | COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING BETA 2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS | Details |
| P 1052 | PEARL THERAPEUTICS, INC. | COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS | Details |
| P 1053 | WYETH HOLDINGS LLC | CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES | Details |
| P 1054 | PFIZER INC. | N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS | Details |
| P 1055 | IONIS PHARMACEUTICALS, INC. | MODULATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) EXPRESSION | Details |
| P 1056 | ASTRAZENECA AB | METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMAB | Details |
| P 1057 | NUCANA PLC | NEW 2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DERIVATIVES AS ANTI-CANCER COMPOUNDS | Details |
| P 1058 | PFIZER INC. | NOVEL SELECTIVE ANDROGEN RECEPTOR MODULATORS | Details |
| P 1059 | PFIZER INC. | BENZIMIDAZOLE DERIVATIVES | Details |
| P 1060 | INCYTE HOLDINGS CORPORATION | SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS | Details |
| P 1061 | INCYTE HOLDINGS CORPORATION | HETEROCYCLYLAMINES AS PI3K INHIBITORS | Details |
| P 1062 | ARRAY BIOPHARMA, INC. | PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS | Details |
| P 1063 | MEDIMMUNE, LLC | ANTIBODIES THAT SPECIFICALLY BIND STAPHYLOCOCCUS AUREUS ALPHA TOXIN AND METHODS OF USE | Details |
| P 1064 | MODUGROUP LIMITED | TILED PITCHED ROOFS | Details |
| P 1065 | MERCK SHARP & DOHME LLC | 5-PHENOXY-3H-PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS HIV REVERSE TRANSCRIPTASE INHIBITORS | Details |
| P 1066 | PFIZER INC. | MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | Details |
| P 1067 | INCYTE HOLDINGS CORPORATION | BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS | Details |
| P 1068 | ASTRAZENECA AB | POLYCYCLIC AMIDE DERIVATIVES AS CDK9 INHIBITORS | Details |
| P 1069 | PIERIS PHARMACEUTICALS GmbH and ASTRAZENECA AB | TEAR LIPOCALIN MUTEINS BINDING IL-4 R ALPHA | Details |
| P 1070 | ASTRAZENECA AB | METHODS FOR INCREASING FORCED EXPIRATORY VOLUME IN ASTHMATICS USING BENRALIZUMAB | Details |
| P 1071 | ASTRAZENECA AB | CRYSTALLINE FORMS OF THE COMPOUND 4-(6-CHLORO-2,3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE | Details |
| P 1072 | BIOGEN MA INC. | NOVEL FUSED PYRIDINE COMPOUNDS AS CASEIN KINASE INHIBITORS | Details |
| P 1073 | MEDIMMUNE, LLC | REFRIGERATOR-TEMPERATURE STABLE INFLUENZA VACCINE COMPOSITIONS | Details |
| P 1074 | MEDIVATION TECHNOLOGIES LLC | DIHYDROPYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) | Details |
| P 1075 | PFIZER INC. | PYRROLO [2, 3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF JANUS KINASES (JAK) | Details |
| P 1076 | NOVO NORDISK A/S | ANTI-NKG2A ANTIBODIES AND USES THEREOF | Details |
| P 1077 | MEDIMMUNE LIMITED | TARGETED BINDING AGENTS AGAINST B7-H1 | Details |
| P 1078 | MEDIMMUNE LIMITED | ANTI-B7-H1 AND ANTI-CTLA-4 ANTIBODIES FOR TREATING NON-SMALL CELL LUNG CANCER | Details |
| P 1079 | ACERTA PHARMA B.V. | SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE | Details |
| P 1080 | NORTHERN TRUST CORPORATION 50 South Lasalle Street Chicago IL 60603 USA | SYSTEMS AND METHODS FOR DIGITAL IDENTITY MANAGEMENT AND PERMISSION CONTROLS WITHIN DISTRIBUTED NETWORK NODES | Details |
| P 1081 | ASTRAZENECA AB | METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB | Details |
| P 1082 | MEDIMMUNE LIMITED | ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS | Details |
| P 1083 | DB GROUP (HOLDINGS) LIMITED | ACTIVATOR COMPOSITION AND METHOD FOR MAKING CONCRETE | Details |
| P 1084 | DB GROUP (HOLDINGS) LIMITED | CEMENTITIOUS BINDERS, ACTIVATORS AND METHODS FOR MAKING CONCRETE | Details |
| P 1085 | INNATE PHARMA | TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES | Details |
| P 1086 | ASTRAZENECA AB | 1-[2-(AMINOMETHYL)BENZYL]-2-THIOXO-1,2,3,5-TETRAHYDRO-4H-PYRROLO[3,2-D]PYRIMIDIN-4-ONES AS INHIBITORS OF MYELOPEROXIDASE | Details |
| P 1087 | MEDIMMUNE LIMITED | ANTIBODIES DIRECTED TO ALPHAVBETA6 AND USES THEREOF | Details |
| P 1088 | CALITHERA BIOSCIENCES, INC. | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | Details |
| P 1089 | ASTRAZENECA AB | PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS | Details |
| P 1090 | ARDEA BIOSCIENCES, INC. | THIOACETATE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | Details |
| P 1091 | ASTRAZENECA AB | ESTROGEN RECEPTOR MODULATORS | Details |
| P 1092 | ASTRAZENECA AB | [2,2,4]TRIAZOLO[4,3-B]PYRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES | Details |
| P 1093 | PEARL THERAPEUTICS, INC. | COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING BETA-2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS | Details |
| P 1094 | ASTRAZENECA AB | 6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLINE DERIVATIVE USEFUL IN THE TREATMENT OF CANCER | Details |
| P 1095 | NGM BIOPHARMACEUTICALS, INC. | ANTIBODIES BINDING BETA KLOTHO DOMAIN 2 AND METHODS OF USE THEREOF | Details |
| P 1096 | ALPHACORE PHARMA LLC | DELIVERY OF CHOLESTERYL ESTER TO STEROIDOGENIC TISSUES | Details |
| P 1097 | DAIICHI SANKYO COMPANY, LIMITED | ANTIBODY-DRUG CONJUGATE | Details |
| P 1098 | DAIICHI SANKYO COMPANY, LIMITED | ANTI-HER2 ANTIBODY-DRUG CONJUGATE | Details |
| P 1099 | MEDIMMUNE LIMITED | CTLA-4 VARIANTS | Details |
| P 1100 | PFIZER INC. | PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES | Details |
| P 1101 | PFIZER INC. | AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS | Details |
| P 1102 | MINERVA NEUROSCIENCES, INC. | USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SLEEP DISORDERS | Details |
| P 1103 | ASTRAZENECA AB | (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES ASDIPEPTIDYL PEPTIDASE I INHIBITORS | Details |
| P 1104 | ASTRAZENECA AB | OPTICALLY ACTIVE 2-ARYL CYCLOPROPANE CARBOXAMIDE INTERMEDIATE | Details |
| P 1105 | ViiV HEALTHCARE UK (NO. 4) LIMITED | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT | Details |
| P 1106 | PEARL THERAPEUTICS, INC. | COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS | Details |
| P 1107 | PEARL THERAPEUTICS, INC. | COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS | Details |
| P 1108 | ASTRAZENECA AB | THERAPEUTIC POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME | Details |
| P 1109 | INTRATUS, INC. | METHODS AND COMPOSITIONS FOR SUSTAINED DELIVERY OF DRUGS | Details |
| P 1110 | NOVO NORDISK HEALTH CARE AG | PYRROLOPYRROLE COMPOSITIONS AS PYRUVATE KINASE (PKR) ACTIVATORS | Details |
| P 1111 | INCYTE HOLDINGS CORPORATION | USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF P13K RELATED DISORDERS | Details |
| P 1112 | MERCK SHARP & DOHME LLC | 4-AMINO-2-(1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL)-6-OXO-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES AND THE RESPECTIVE (1H-INDAZOL-3-YL) DERIVATIVES AS CGMP MODULATORS FOR TREATING CARDIOVASCULAR DISEASES | Details |
| P 1113 | ASTRAZENECA AB | MACROCYCLIC MCL1 INHIBITORS FOR TREATING CANCER | Details |
| P 1114 | AMYLIN PARMACEUTICALS, LLC & ASTRAZENECA PHARMACEUTICALS LP | EXENDIN FOR TREATING DIABETES AND REDUCING BODY WEIGHT | Details |
| P 1115 | MEDIMMUNE, LLC | MODIFIED POLYPEPTIDES FOR BISPECIFIC ANTIBODY SCAFFOLDS | Details |
| P 1116 | MEDIMMUNE LIMITED | CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND A TNFA ANTAGONIST DOMAIN | Details |
| P 1117 | ViiV HEALTHCARE UK (NO. 5) LIMITED | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | Details |
| P 1118 | MEDIMMUNE, LLC | METHOD FOR PURIFYING IMMUNOCONJUGATES | Details |
| P 1119 | PELOTON THERAPEUTICS, INC. | ARYL ETHERS AND USES THEREOF | Details |
| P 1120 | MERCK SHARP & DOHME B.V. | APPLICATOR FOR INSERTING AN IMPLANT | Details |
| P 1121 | ASTRAZENECA AB | STABLE ANTI-IFNAR1 FORMULATION | Details |
| P 1122 | INCYTE CORPORATION | 1H-PYRROLO[2,3-C]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-C]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS | Details |
| P 1123 | INCYTE CORPORATION | SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR | Details |
| P 1124 | CALITHERA BIOSCIENCES, INC. | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | Details |
| P 1125 | THE UNIVERSITY OF CHICAGO | ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TREATING DYSTROPHIES | Details |
| P 1126 | MEDIMMUNE, LLC | BINDING MOLECULES SPECIFIC FOR ASCT2 AND USES THEREOF | Details |
| P 1127 | MEDIMMUNE, LLC | METHODS OF PRODUCING IMMUNOCONJUGATES | Details |
| P 1128 | MEDIMMUNE, LLC | PURIFIED ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES | Details |
| P 1129 | ZS PHARMA, INC. | USE OF A ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA | Details |
| P 1130 | ASTRAZENECA AB & ASTRAZENECA UK LIMITED | IMMEDIATE RELEASE TABLET FORMULATIONS | Details |
| P 1131 | DAIICHI SANKYO COMPANY, LIMITED AND SAPPORO MEDICAL UNIVERSITY | ANTI-TROP2 ANTIBODY-DRUG CONJUGATE | Details |
| P 1132 | ASTRAZENECA AB | 2-{2,4,5-SUBSTITUTED-ANILINO}PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER | Details |
| P 1133 | INNATE PHARMA | NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES | Details |
| P 1134 | MEDIMMUNE LIMITED | ANTIBODIES TO AMYLOID BETA | Details |
| P 1135 | PFIZER PRODUCTS INC. | ANTI-CTLA-4 ANTIBODY COMPOSITIONS | Details |
| P 1136 | VERTEX PHARMACEUTICALS INCORPORATED | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES | Details |
| P 1137 | ASTRAZENECA AB | METHODS FOR INCREASING FORCED EXPIRATORY VOLUME IN ASTHMATICS USING BENRALIZUMAB | Details |
| P 1138 | PAPIER-METTLER KG | PLASTIC BAG AND HAND STRAP FOR A PLASTIC BAG | Details |
| P 1139 | MEDIMMUNE LIMITED | PROTEASE-RESISTANT LIPIDATED GLP-1 ANALOGS | Details |
| P 1140 | TRILINK BIO TECHNOLOGIES, LLC | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | Details |
| P 1141 | MERCK SHARP & DOHME B.V. | 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK-INHIBITORS | Details |
| P 1142 | MEDIMMUNE, LLC AND HUMABS BIOMED S.A. | NEUTRALIZING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF | Details |
| P 1143 | MORPHOSYS AG | ANTI-CD19 ANTIBODY FORMULATIONS | Details |
| P 1144 | INCYTE CORPORATION | SALTS OF PI3K INHIBITOR AND PROCESSES FOR THEIR PREPARATION | Details |
| P 1145 | INCYTE CORPORATION | BIPYRAZOLE SALT AS JAK INHIBITOR | Details |
| P 1146 | PHARMACIA & UPJOHN COMPANY LLC | A CRYSTAL COMPRISING AN L-MALIC ACID SALT OF N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE FOR USE AS A MEDICAMENT | Details |
| P 1147 | MERCK SHARP & DOHME B.V. | 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK-INHIBITORS | Details |
| P 1148 | INSPIRNA, INC. | INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF | Details |
| P 1149 | ACERTA PHARMA B.V. | THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A BCL-2 INHIBITOR | Details |
| P 1150 | MERCK SHARP & DOHME LLC | A CONDITIONAL REPLICATING CYTOMEGALOVIRUS AS A VACCINE FOR CMV | Details |
| P 1151 | INNATE PHARMA | NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES | Details |
| P 1152 | PFIZER INC. | BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS | Details |
| P 1153 | MEDIMMUNE LIMITED | BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF | Details |
| P 1154 | PFIZER INC. | SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS | Details |
| P 1155 | COMPUGEN LTD | ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF | Details |
| P 1156 | ASTRAZENECA AB | AMINO-TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER | Details |
| P 1157 | MERCK SHARP & DOHME LLC | BENZO[B]THIOPHENE COMPOUNDS AS STING AGONISTS | Details |
| P 1158 | MERCK SHARP & DOHME LLC | 4'-SUBSTITUTED NUCLEOSIDE-DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS | Details |
| P 1159 | ARQULE, INC. | TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS OF USE THEREOF | Details |
| P 1160 | PAPIER-METTLER KG | HAND STRAP FOR A PLASTIC BAG | Details |
| P 1161 | ACERTA PHARMA B.V. | THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PD-1 INHIBITOR AND/OR A PD-L1 INHIBITOR | Details |
| P 1162 | MODERNATX, INC. | MODIFIED RNA ENCODING VEGF-A POLYPEPTIDES, FORMULATIONS, AND USES RELATING THERETO | Details |
| P 1163 | MEDIMMUNE LIMITED AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | IMPROVED ALPHA-V BETA-B ANTIBODIES | Details |
| P 1164 | ASTRAZENECA AB | STABLE, AQUEOUS ANTIBODY FORMULATIONS | Details |
| P 1165 | MEDIMMUNE LIMITED | ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF | Details |
| P 1166 | ASTRAZENECA AB | 8-[6-[3-(AMINO)PROPOXY]-1-ISOPROPYL-IMIDAZO[4,5-C]QUINOLIN-2-ONE DERIVATIVES AS SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE FOR THE TREATMENT OF CANCER | Details |
| P 1167 | ACERTA PHARMA B.V. | SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE | Details |
| P 1168 | ASTRAZENECA AB | POLYCYCLIC AMIDE DERIVATIVES AS CDK9 INHIBITORS | Details |
| P 1169 | ASTRAZENECA AB | METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB | Details |
| P 1170 | MEDIMMUNE LIMITED | RSV-SPECIFIC ANTIBODIES AND FUNCTIONAL PARTS THEREOF | Details |
| P 1171 | AMYLIN PHARMACEUTICALS, LLC AND ASTRAZENECA PHARMACEUTICALS LP | SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS | Details |
| P 1172 | NORTHERN TRUST CORPORATION | SYSTEMS AND METHODS FOR GENERATING, UPLOADING, AND EXECUTING CODES BLOCKS WITHIN DISTRIBUTED NETWORK NODES | Details |
| P 1173 | NORTHERN TRUST CORPORATION | SYSTEMS AND METHODS FOR GENERATING AND MAINTAINING IMMUTABLE DIGITAL MEETING RECORDS WITHIN DISTRIBUTED NETWORK NODES | Details |
| P 1174 | ASTRAZENECA AB | 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS | Details |
| P 1175 | MEDIMMUNE LLC | EMBEDDED MULTIPLE-PART SENSOR WITHIN A PLUNGER ROD TO CAPTURE AND TRANSMIT INJECTION INFORMATION | Details |
| P 1176 | MEDIMMUNE LIMITED | GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY | Details |
| P 1177 | GENMAB S/S | ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA | Details |
| P 1178 | HUTCHISON MEDIPHARMA LIMITED | SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS | Details |
| P 1179 | REDX PHARMA PLC | N-PYRIDINYL ACETAMIDE DERIVATIVES AS WNT SIGNALLING PATHWAY INHIBITORS | Details |
| P 1180 | INCYTE CORPORATION | PROCESSES FOR PREPARING (1-(3-FLUORO-2-(TRIFLUOROMETHYL)ISONICOTINYL)PIPERIDINE-4-ONE) | Details |
| P 1181 | ASTRAZENECA AB | IMPROVED PROCESS FOR THE PREPARATION OF OSIMERTINIB (AZD9291) OR A SALT THEREOF, AND "AZD9291 ANILINE" OR A SALT THEREOF | Details |
| P 1182 | ASTRAZENECA AB AND EOLAS THERAPEUTICS, INC. | HALO-SUBSTITUTED PIPERIDINES AS OREXIN RECEPTOR MODULATORS | Details |
| P 1183 | MEDIMMUNE LIMITED | IN SILICO DESIGN OF MAMMALIAN PROMOTERS WITH USER-DEFINED FUNCTIONALITY | Details |
| P 1184 | MERCK SHARP & DOHME LLC | ANTI-LAG3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS | Details |
| P 1185 | MEDIMMUNE LIMITED | A NOVEL IL33 FORM, MUTATED FORMS OF IL33, ANTIBODIES, ASSAYS AND METHODS OF USING THE SAME | Details |
| P 1186 | DAIICHI SANKYO COMPANY, LIMITED AND DAIICHI SANKYO EUROPE GmbH | ANTI-HER3 ANTIBODY-DRUG CONJUGATE | Details |
| P 1187 | IONIS PHARMACEUTICALS, INC. | COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION | Details |
| P 1188 | HUTCHISON MEDIPHARMA LIMITED | CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR | Details |
| P 1189 | PFIZER INC. | DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS | Details |
| P 1190 | VERTEX PHARMACEUTICALS INCORPORATED | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Details |
| P 1191 | MEDIMMUNE LIMITED | COMPOUNDS AND CONJUGATES THEREOF | Details |
| P 1192 | ASTRAZENECA AB | PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 | Details |
| P 1193 | VERTEX PHARMACEUTICALS INCORPORATED | MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR | Details |
| P 1194 | ASTRAZENECA AB | USE OF C-MET INHIBITORS TO TREAT CANCERS HARBOURING MET MUTATIONS | Details |
| P 1195 | ACCELERON PHARMA INC. | TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF | Details |
| P 1196 | ASTRAZENECA AB | COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER | Details |
| P 1197 | MEDIMMUNE LIMITED & MEDIMMUNE, LLC | PURIFICATION OF RECOMBINANTLY PRODUCED POLYPEPTIDES | Details |
| P 1198 | MERCK SHARP & DOHME LLC | METHODS FOR TREATMENT AND PROPHYLAXIS OF HIV AND AIDS | Details |
| P 1199 | ASTRAZENECA AB | STABLE ANTI-IFNAR1 FORMULATION | Details |
| P 1200 | DAIICHI SANKYO COMPANY, LIMITED | PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYL METHYL GROUP | Details |
| P 1201 | ASTRAZENECA AB | 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS | Details |
| P 1202 | FLEX MARINE POWER LTD | AXIAL FLOW TURBINE APPARATUS | Details |
| P 1203 | MEDIMMUNE, LLC | NEUTRALIZING ANTI-INFLUENZA BINDING MOLECULES AND USES THEREOF | Details |
| P 1204 | HALOZYME, INC. | SOLUBLE HYALURONIDASE COMPOSITION | Details |
| P 1205 | C4x DISCOVERY LIMITED | THERAPEUTIC COMPOUNDS | Details |
| P 1206 | ASTRAZENECA AB | 8-[6-[3-(AMINO)PROPOXY]-3-PYRIDYL]-1-ISOPROPYL-IMIDAZO[4,5-C]QUINOLIN-2-ONE DERIVATIVES AS SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE | Details |
| P 1207 | MedImmune Limited and two others | ANTIBODIES AGAINST LIF AND USES THEREOF | Details |
| P 1208 | ACCELERON PHARMA INC., ADIMAB, LLC | ACTIVIN TYPE 2 RECEPTOR BINDING PROTEINS AND USES THEREOF | Details |
| P 1209 | DAIICHI SANKYO COMPANY, LIMITED | ANTI-CDH6 ANTIBODY AND ANTI-CDH6 ANTIBODY-DRUG CONJUGATE | Details |
| P 1210 | PAPIER-METTLER KG | PLASTIC BAG | Details |
| P 1211 | INCYTE CORPORATION | COMBINATION THERAPY WITH AN ANTI-CD19 ANTIBODY AND A PURINE ANALOG | Details |
| P 1212 | INCYTE CORPORATION | COMBINATION THERAPY WITH AN ANTI-CD19 ANTIBODY AND A NITROGEN MUSTARD | Details |
| P 1213 | VERTEX PHARMACEUTICALS INCORPORATED | SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS | Details |
| P 1214 | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. | AUDIO BANDWIDTH EXTENSION DECODER, CORRESPONDING METHOD AND COMPUTER PROGRAM | Details |
| P 1215 | HARPOON THERAPEUTICS, INC. | TRISPECIFIC PROTEINS AND METHODS OF USE | Details |
| P 1216 | ASTRAZENECA AB AND CANCER RESEARCH TECHNOLOGY LIMITED | PURINONE DERIVATIVES AND THEIR USE IN TREATING CANCER | Details |